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    The invention of capsule endoscopy (CE) made the non-invasive monitoring of 
the entire small bowel possible and became the primary means for diagnosing small 
bowel pathology. In the last decade, capsule robots have been transformed from 
diagnostic devices into a widely studied biomedical platform with the potential for active 
locomotion, drug delivery and therapeutic capabilities. To perform accurate on-site drug 
release and therapy, it is necessary for a capsule robot to be able to attach to the intestinal 
tissue and maintain its position long-term. Design challenges derive from the task of 
long-term mucosal adhesion which requires firm, quick-response attachment without 
causing unacceptable trauma or complications.   
In this work, we initiate a study to address the challenges associated with long-
term attachment and explore possible solutions. First, a method to quantify the 
attachment behavior of parasites was developed. This method could be applied to studies 
of parasite biomechanics and the results may help medical device researchers better 
mimic the unique functional morphology of intestinal parasites. Second, a tissue 
attachment mechanism inspired by the parasite attachment approach was designed, 
optimized and tested for safety and adhesive capabilities on animal models in vitro and in 
vivo. Next, a long-term, non-invasive, non-restrictive implantation capsule robot for 
delivering and implanting a biosensor within the tissue attachment mechanism in the 
intestine was developed. Testing on a live porcine model provided evidence that this is a 
promising approach for implanting a biosensor within the small intestine. Finally, a finite 
element method for simulating the attachment interaction between the intestine and 
capsule was applied with the goal of providing a detailed guide to further system 
optimization. The prototype of this study offers more than 40 hours in vivo attachment 
without causing serious damage and has the potential to be translated into clinical usage.  
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CHAPTER 1. INTRODUCTION: THE HISTORY, STATUS AND FUTURE OF IN 
VIVO CAPSULE ROBOT. 
1.1 The history of gastrointestinal diagnosis 
The gastrointestinal (GI) tract is the large, hollow, tubular organ system that 
extends from the mouth to the anus. It has an average length of 7 m and is mainly 
responsible for digestion of food, absorption of nutrients and elimination of waste 
1
. The 
GI tract is covered by a large layer of muscle. The peristalsis of these muscles and the 
release of hormones and enzymes enable the digestion process. As one of the most 
dynamic organ systems of human body, diseases always accompany with it. Digestive 
diseases encompass more than 40 acute and chronic conditions of the GI tract ranging 
from common digestive disorders to serious, life-threatening diseases (e.g. 
gastroesophageal reflux disease, obscure gastrointestinal bleeding, intestinal tumors, 
irritable bowel syndrome and chronic constipation 
2)
. Approximately 60-70 million 
Americans currently are suffered from general digestive diseases 
3
. The corresponding 
mortality exceeds two hundred thousand annually 
4
 which is 8% - 9% of total U.S. 
mortality. Even if only the small bowel disease is considered, as many as 70,000 new 
cases are diagnosed in the United States each year. In 2004, $141.8 billion was spent 
overall on the digestive disease treatment, and 68% of the costs were direct medical 
expenses 
5
.  
In order to diagnose and treat such diseases, physicians have been eager to 
observe the interior of the gastrointestinal tract for centuries. A radiographic approach 
may be a solution. But the ability for detailed observation and accurate identification of 
bleeding sources and inflammatory sites are limited 
6
. Endoscopy— which literally 
2 
 
means “looking inside” (from the Greek “endo” meaning “within” and “scopy” meaning 
“watching”) — was first conceptually proposed by French urologist Antonin Jean 
Desormeaux, and first technically invented by German physician Philipp Bozzini in 1805. 
This very first prototype was a rigid instrument that used large lumens to direct external 
candle light into the human body 
7
. The GI tract is clearly convoluted, soft and dark. 
Flexible body structure and safe “cold light” (no heat generated to threaten nearby viscera) 
were quickly believed to be the two key factors to a practicable endoscopy. Efforts to 
achieve these two requirements through product iterations have not stopped since then. 
Modern flexible fiber-optic endoscopy, which transmitted “cold light” from an outside 
source through fiber-optic bundle and was conceptually introduced to the clinical in the 
1920s 
8
, was first built by a graduate student in physics named Larry Curtiss in 1958. It 
soon became the standard tool for visualizing GI tract 
9
. Through studying the 
composition and distribution of GI tract folds, the mucosal architecture and the 
submucosal vascular pattern through endoscopic visualization, experienced endoscopists 
can detect mucosal pathologies 
10
. The main benefit of using endoscopy compared with 
the conventional operation is that it is a minimally invasive procedure. Since the device is 
inserted via natural orifices the stress/trauma placed on the body is much less. In other 
words, it generally produces quicker procedures and quicker recovery times 
11
. With the 
development of advanced imaging system in the last twenty years, the ability to describe 
and characterize abnormal structure and lesions in detail has improved significantly 
12
. 
Meanwhile, by means of integrating the operation tools on the tip of flexible endoscopy, 
the surgeon can not only view the internal organs but can also perform minor surgery at 
the same time 
13
. 
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Everything has its borders and limitations. Fiber-optic endoscopy is no exception. 
It causes discomfort because of the pushing movement of the wide, flexible cable and 
usually necessitates the sedation of the patient 
14
. It can enter the esophagus, upper small 
intestine and colon, but it lacks the accessibility of the whole small intestine due to its 
limited length 
15
. There is a clinical need for improved methods of examining the whole 
small intestine. In 1981, an electro-optical engineer Gavriel Iddan who previously 
dedicated his life to developing guided-missile technology was challenged by his 
neighbor, gastroenterologist Eitan Scapa, to invent an endoscopy that can make its way 
through the entire GI tract 
16
. After two decades of development, Iddan was issued a 
patent for his wireless capsule endoscopy (CE) in 1997 
17
. This innovative product was 
mainly benefitted by three technologies: complementary metal oxide silicon (CMOS) 
image sensors, application-specific integrated circuit (ASIC) devices and white-light-
emitting diode (LED) illumination 
18
. The image is obtained through a CMOS sensor, 
transmitted using radio-telemetry and stored on a wearable data recorder. Without the 
restriction of a cable, the capsule endoscopy can be swallowed and propelled by 
peristalsis through the GI tract and can therefore, cause much less discomfort. The CE 
was first introduced commercially in 2000. Various clinical trials have shown the 
efficacy of this non-invasive technique to improve diagnostic outcomes among a variety 
of GI diseases especially small bowel diseases. In short, CE allows the visualization of 
mucosal alterations associated with celiac disease and could perform an accurate 
diagnosis of small intestine Crohn’s disease 19. It could facilitate diagnosis of small 
intestine polyps and tumors and is a valid device for the surveillance of hereditary 
polyposis syndromes 
20–22
.  To date, the most prevalent clinically used CEs worldwide are 
4 
 
PillCam SB3 (ESO 3 and COLON 2 for the esophagoscopy and colonoscopy version, 
Medtronic Plc., Minneapolis, MN, United States), EndoCapsule (Olympus Corporation, 
Tokyo, Japan), CapsoCam SV-2 (CapsoVision Inc., CA, United States), MiroCam v2 
(IntroMedic Co. Ltd., Seoul, South Korea) and OMOM (Jinshan Science and Technology 
Co. Ltd., Chongqing, China).  The first two are Food and Drug Administration (FDA) 
certified. All the capsules listed above are measured around 30 × 11 mm, 4g weight, takes 
2-20 images per second and could operate up to 15 h 
23
.  
1.2 The status of CE 
Although the CE was invented as a pure diagnosis device, clinical capsules have 
also been developed recently for purposes besides visualization recently. Given Imaging 
Ltd.’s Bravo capsule is the world’s first wireless pH monitoring system that can measure 
the pH level in the esophagus to diagnose the heartburn and gastroesophageal reflux 
disease (GERD). It attaches to the esophagus by pinning itself to the suctioned tissue and 
transmits pH data wirelessly to a pager-sized receiver. Such a procedure could last up to 
48 hours, depending on the physician’s requests 24. Similarly, the SmartPill capsule 
provided by the same company offers the ability to measure the pressure, pH and 
temperature through the whole GI tract to assess GI motility. The CorTemp (HQ Inc., 
Palmetto, FL, United States) telemetry capsule, originally developed by the Johns 
Hopkins Applied Physics Laboratory in collaboration with the Goddard Space Flight 
Center, is an FDA cleared device that monitors internal body temperature as it travels 
through the digestive system. It passes the data harmlessly through the body to the 
recorder worn on the outside of the body. It has been proved to be a valid way for GI tract 
temperature measurement 
25
. The Enterion Capsule (Quotient Clinical, England) is used 
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to investigate the absorption of drugs from the GI tract. Triggered by an external 
oscillating magnetic field, tt can deliver a wide range of different drug formulations 
(including liquid and powder) into any region of the gut. The IntelliCap capsule 
(Medimetrics, Netherlands) is developed for quickly executed in-vivo drug development 
studies. It could position itself by pH measurements and target a drug formulation with 
controlled amount or capture fluid sample for microbiome profiling at a targeted location 
26,27
. 
Overall, these commercial capsules expand the scope of endoscopic application; 
they show the potential of providing minimal invasive diagnosis method to a larger 
variety of clinical fields. But several technical limitations still prevent the prevalence of 
capsule approach. In general, all of the capsule robots are subjected to passive movement 
(that is, pushed by the peristaltic force of the GI tract). A localization, orientation or 
adhesion mechanism that could position a capsule in respect to a body landmark or 
tridimensional world frame for a sufficiently long-term is missing. An effective drug 
releas and tissue manipulation system for localized therapy and surgery has not been fully 
developed for clinical use.  The interaction between capsule and GI tract has not been 
thoroughly understood, and cannot be precisely predicted 
28
. 
1.3 The potential strategies to overcome the limitations 
In the last ten years, several technical solutions to addressing the above 
limitations have been developed thanks to the improvement of semiconductor and 
microfabrication technology. Even so many of them lack the opportunities to be launched 
on the market due to their complex system and the difficulty of manufacturing them.  In 
the following paragraphs, scientific publications and laboratory products have been 
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selected and expounded upon. These research achievements are the pertinent progress in 
capsule robotic technology that either shows great promise or has taken relevant steps in 
bringing technology to where we are today. From here, the function of CE has far 
exceeded its original development purpose. To clarify, in the rest of this dissertation, the 
CE will be only used to represent the commercial clinical capsule endoscopy, which 
helps the recording of the GI tract. The laboratory products that have similar capsule-like 
shape but more are versatile will be called capsule robots (CR). 
1.3.1 CR locomotion 
The idea of giving CRs the active locomotion ability came at the same time as the 
birth of CE. CE has proved its superiority in the GI tract. It is effective in disease 
diagnosis and leads to much less pain than fiber-optic endoscopy. Still, clinical trials have 
shown the nonexcretion may occur with the possibility up to 5% 
29
. Although capsule 
retention is usually clinically asymptomatic, it may require either endoscopic or surgical 
removal to avoid further complications like intestinal perforation 
30,31
. The main reasons 
for CE nonexcretion are believed to be small bowel obstruction caused by disease and the 
lack of active mobilization capacity to pass the rugged GI tract or narrow lumens 
32
. If the 
CE can be controlled to move back and forth along the GI tract, a lower nonexcretion rate 
can be achieved and a more thorough and active diagnosis can be performed. 
Additionally, the controlled locomotion can be integrated into any CR’s targeted therapy 
and data collection system. To date, the two most investigated approaches for CR 
locomotion are mechanical and magnetic actuation approaches. Mechanical actuation 
allows the CR to mechanically crawl through the GI tract. The principles are either 
inspired by nature (insect legs and inchworm-like locomotion) or mainstream industrial 
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solutions (wheels). The study of legged locomotion can be traced back to 2004 to 
Menciassi et al, who invented a type of mini-leg to climb on the intestinal wall 
33
. The 
mini-leg is driven by a shape memory alloy (SMA) actuator and provides 60 mN 
locomotion force in vitro experiment on the porcine intestine tissue. The legged approach 
was soon carried forward by Quirini et al
34,35
 and Valdastri et al 
36
, whose prototypes— 
which use up to 12 legs— have been developed to generate an average of 0.63 N 
propulsive force at each leg tip.  
 
Fig.1-1  Isometric and side view (with hidden body) of the 12-legged capsule 
36
. 
In those models, legs were divided into several sets which can open and close 
independently. This design allowed for synchronized motion and the prevention of back 
slippage while opening a single leg set. A balloon in the front of the ICR distended 
collapsed tissue. In the same year as Menciassi initiated the leg study, Kim et al 
developed an earthworm-like locomotive mechanism which biomimicked micro hooks of 
an insect and moved via an anchor-and-pull effect using SMA 
37
. After that, different 
types of actuators— such as piezo actuator 38 or magnetic actuator— were tried on the 
earthworm-like mechanism. A maximum velocity of 2.33 mm/s could be reached during 
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an in vitro bench test using dead intestine tissue. The most recent iterations of the 
earthworm-like actuation mechanism were done during 2013 and 2014. In 2013, Chen et 
al developed an earthworm-like colon-traversing robot that utilized a power-transmitting 
coil for wireless power supply 
39
. The capsule body was covered by balloon to improve 
the safety of mucosal contact. Next year, the same group combined the leg idea with the 
earthworm biomimicry. They developed a CR that applied the earthworm-like propulsion 
principle but also utilized extending spiral legs for anchoring on the GI wall 
40
. In 2010, 
Sliker et al designed a micropatterned tread with polydimethylsiloxane (PDMS) to enable 
mobile capsule crawlers inside the body. They performed an in vivo comparison of a 
smooth PDMS covered wheel and a patterned PDMS covered wheel in porcine model. 
The results indicated that the patterned wheel outperformed the smooth wheel 
41
. 
Following works form the same team showed the active micro-tread track system was 
capable of forward and reverse mobility for both planar and collapsed lumen tissue 
environments 
42
. In the stomach area, self-propulsion was widely accepted as a feasible 
locomotion method in such a fluid filled environment. Morita et al developed a fin 
structure to be actuated by an external magnetic field 
43
. This fin mechanism was 
assembled on a commercial CE and could propel the capsule in dog’s stomach at 50 
mm/s. The same concept can also be found in Kósa et al’ s work 44,45. They utilized an 
MRI system to induce alternating currents in coils that assemble on a tail mechanism. 
The tail could vibrate to generate several mm/s speed in a water tank. Tortora et al 
developed a submarine-like CR with four micro-propellers on its end 
46
. It was tested in 
the porcine stomach and a 15 mm/s speed was achieved. All these techniques have 
average higher locomotion speed. But the requirement of a fluid-filled environment 
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imposes restrictions on the usage in a whole GI tract. Other novel mechanical locomotion 
approaches include generating electrical stimulus to contract the small intestine to stop or 
active the ICR locomotion. However the authors noticed the presence of serious safety 
issues; electric stimulation may cause damage to electrically sensitive organs, such as the 
liver, and may disturb natural peristalsis 
47,48
. 
So far, none of those designs have been translating to clinical trials due to on-
board power limitation and mechanical complexity. The mechanical actuators take a large 
portion of the on-board volume— hence the limited space for the integration of a power 
supply and other functional systems. The safety concern evoked by the mechanical 
contact between locomotion mechanism and the mucosa also restricted the clinical 
application of those approaches. It occurred to researchers that an external powered 
magnetic driving method could be an alternative solution. Magnetic actuation method 
was first introduced as an approach to obtain propulsion force in the liquid-filled 
environment— such as the stomach— and then be widely studied in other GI area. In the 
stomach, the mechanical locomotion method designed for tubular geometries (intestine or 
esophagus) performed poorly due to the large, open space 
49
. The concept of magnetic 
actuation is inducing a magnetic force on a CR with embedded magnet via an external 
uniform magnetic field. The magnetic gradient in space induces relative motion and 
controlled orientation of the CR. The main technical obstacle is the exponentially 
decreased magnetic coupling force with distance 
50
. In 2007, Carpi et al conducted the 
first in vitro magnetic actuation trial with a magnetically coated commercial CE 
51
. This 
study opened a new window for the locomotion development. In 2010 and 2012, 
Valdastri et al 
52
 and Lien et al 
53
 successfully utilized an external hand-held magnet to 
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adjust the camera view angle and capsule rotation. Swain and Keller et al published their 
human study with a swallowable magnetic capsule in 2010 
54,55
. The authors reported the 
difficulty in transmitting the capsule through esophagus due to the insufficient magnetic 
force. Generally, hand-held magnetic controls are easier to handle and implement, but 
also make it harder to achieve precise movements and enough magnetic strength. Ciuti et 
al compared the effectiveness of capsule locomotion actuated by robotic controlled 
magnetic field and hand-held magnets 
56
. The results showed the advantage of robotic 
controlled magnetic system in both position accessibility and movement precision.  
 
Fig.1-2 Robotic magnetic actuation system composed of a human-machine interface 
(HMI), the robotic arm system and the endoscopic capsular device 
56
. 
On this account, the robotic controlled magnetic actuation— which generating a 
larger magnetic field and more accurate position control— became overwhelming in this 
field in the recent past. Arezzo et al compared the performance of a robotically-driven 
magnetic capsule for colonoscopy system to standard colonoscopy on an ex vivo swine 
bowel. The author found that the robotic capsule system could significantly improve the 
11 
 
performance of trainees on the detection procedure compare to using traditional 
colonoscopy. The only cost is increased procedure time 
57
. From 2012 to 2015, plenty of 
robotic controlled magnetic actuation systems were development and studied. They were 
tested on human trials 
58
, utilizing rotating external magnet to induce screw-like capsule 
motion and preventing tissue perforation 
59–61
. They also tested the industrial 6 degree of 
freedom (DoF) serial manipulator to move the permanent magnet 
62
. Overall, the 
magnetic actuation approach showed more potential to be transferred from a research 
technique to clinical application in near future. But with the progress of integrated circuit 
and novel battery technique, the mechanical actuated locomotion may regain the lead. 
1.3.2 CR localization 
Knowledge of the capsule robot position in the GI tract is the key to a precise 
diagnosis, localized therapy and target adhesion 
63
. It is the fundamental requirement for 
an advanced self-controlled CR. Technically speaking, the regular localization 
approaches of a CR utilize either the landmarks in the GI tract, such as a lesion 
64
, or a 
universal coordinate position in space 
65
.  Owing to the elastic nature of the GI tract, it is 
difficult to locate the CR only by the space coordinates. Knowing the tridimensional 
distance from a capsule to a target area cannot provide enough information for any 
external locomotion control.  Though groups have reported 3D localization with an error 
of 1 mm using fluoroscopic imaging, developments must be made in describing a CE’s 
location with respect to anatomical landmarks 
66
. Karargyris et al published their 
Odocapsule prototype, which could providing real-time distance from point of duodenal 
entry to exit from the ileum via mounted passive wheels on its side that operate as an 
“odometer” 67.  In recent years, researchers start to utilize hybrid localization techniques 
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including video tracking and RF signals, to provide comprehensive locational 
information and experimentally verify the concept with a localization error less than 2.3 
cm 
68
. Beside the anatomical landmarks, the different parts of GI tract can also be 
identified due to the significant difference of pressure, pH or temperature features. Our 
ongoing study is about developing a CR subsystem with an integrated pressure and 
temperature sensor and gyroscope to generate the tridimensional pathway of a CR and 
provide localization information 
69
. In addition to localization, the realization of long-
term attachment to a target area of GI tract is another attractive subject. In order for it to 
maintain its position, the CR must have a certain capacity to resist peristalsis and any 
other extraction force (e.g. drag force caused by fluid chyme). The long-term attachment 
is the crucial premise for the enabling of detailed diagnostic, prolonged drug release and 
tissue manipulation. The study of long-term attachment was first subsidiary to the 
locomotion studies. Theoretically, if a capsule could realize controlled locomotion 
against the tissue peristalsis and fluid drag force, then it won’t be difficult to just maintain 
its position through the same mechanism 
70
. An obvious advantage of utilizing the same 
mechanism to locomote and attach is that the motion generated by the locomotion 
mechanism could automatically be used as a detachment solution for the attachment 
procedure. The study of long-term attachment started with legged locomotion system. In 
2006, Karagozler et al developed a legged capsule with biomimetic micro-patterned 
adhesives for resisting peristalsis in the small bowel 
70
. Technically speaking, in vivo 
attachment requires not just a quick and firm response to slippery, moist, elastic tissue 
surface, but also a safe attachment process, which means inflicting minimal damage or 
trauma to the tissue, and no serious complication through the long-term mucosal contact 
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71
. Firm mechanical locomotion and attachment normally rely on the large interactive 
force generated between the attachment end effector and the tissue, while— in order to 
keep the tissue from being damaged— the force cannot exceed the tissue materials 
limitation. This limits opportunity for further improvement. Due to the shortcomings of 
the pure mechanical attachment mentioned above, researchers have sought solutions from 
nature. It is well known that patterning the adhesive surface with certain 
microstructures— like those occurring on the feet of insects, lizards, and in the mouths of 
fish— significantly improves the adhesion strength 72. In 2006, Dodou et al conducted 
experiments on developing mucoadhesive polymers to realize in vivo adhesion 
73
. The 
mucoadhesive is a biomimetic product and its frictional properties may be altered 
reversibly via external stimuli like water or air. Similarly, in 2008, Glass et al developed, 
and tested in vitro, an anchoring mechanism that utilizes pulleys for the distension of 4 
legs that contain biomimetic high friction adhesive pads 
74
. Non-contact method was 
presented in 2014 by Kim et al, who introduced a magnetic belt to be worn over the 
abdomen to restrict movement of a magnetic capsule in the stomach and allow 
monitoring of gastric motility 
75
. This device was tested on a human volunteer using a 
MiroCam capsule that was embedded with permanent magnetic disks. Once swallowed, 
the capsule was maneuvered to a desired location after which the magnet was fastened by 
a belt. This is the only case that an attachment procedure was tested on a human trial. 
None of the aforementioned approaches could realize an attachment for more than 24 
hours. To be used in chronic disease diagnosis monitoring or drug delivery/ absorption 
study, the target duration should be no less than a week. Our previous work developed an 
attachment mechanism which was partly inspired by parasites attachment behavior 
76
. It 
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replicates the scolex structure of parasite in meso-scale. The replication is a combination 
of needle and a sucker structure which could realize in vivo attachment up to 6 days in 
animal study without serious damage to the tissue. An ongoing project is working on 
integrating the attachment mechanism to an implantation capsule robot which could 
deploy the attachment mechanism to a target area in the GI tract. The animal study has 
proven the feasibility of the product and shows promising potential for use in clinical trial.    
1.3.3 CR drug delivery and therapeutics 
Drug delivery system for CR has been a prevalent topic in the last decade both for 
accurate bowel disease treatment and drug absorption study 
77
. Targeting drug delivery 
sites in the GI tract may maximize local drug concentration while minimizing drug side 
effects in unwanted areas 
78
. Of the various prototypes of a drug release system for the 
CRs, which have been designed and fabricated to release drugs at different sections of the 
GI tract in a controlled fashion, the most common drug delivery approaches are the 
mechanical release mechanism. In 1999, the first mechanical release system was reported 
79
. It was built of two slotted sleeves which assemble in staggered manner. An RF signal, 
generated from a distance of 10 cm, activated a resistor that heated a mechanism that 
would rotate the inner sleeve when a temperature of 40 °C was reached. When the inner 
sleeve rotated, its slots aligned with those of the outer sleeve, exposing to the GI fluid the 
drug contained in the inner sleeve. This mechanism was further optimized into a sleeve-
cage pair system to minimize the drug leakage. When the capsule is activated, the cage 
can be popped out by spring from the capsule body and the drug can be dispersed from 
the opened sides and bottom of the cage 
80
.  
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Fig.1-3 Sleeve-cage system drug delivery capsule 
80
.  
A limitation of the slotted release mechanism is that when the viscosity of the 
drug is high or the area is lacking fluid, the spread speed of the drug can be slow. Active 
drug release system was generated in response to that situation. Several studies have 
focused on syringe-like mechanism to propel a piston that would push the drug out of its 
reservoir. For instance, Hongying et al, Cui et al, and Groening et al applied thermal 
expanded elastomeric bellows 
81
, microelectromechanical systems (MEMS) 
82
 and 
hydrogen gas generated by a small gas-producing cell 
83
 respectively to push the piston 
and expel the drug out of its receiver. Due to complexity of the battery, antenna, 
electronic components and other mechanical systems, it was reported only 20% of the 
capsule volume can be used to load the drug 
77
. To overcome the space limitation 
problem, a micro-thruster was developed to replace the volume-consuming mechanical 
system and the effective drug volume could rise up to 30% 
84
. Many efforts have been put 
into the optimization of the inner arrangement of the capsule but the effective drug 
volume never could exceed 40%. With the popularity of the external magnetic field 
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actuation study, the usage of magnetic interactions between internal on-board permanent 
magnets and an external permanent magnet provides a possible solution to keep 
increasing the drug volume. Pirmoradi’s group introduced a magnetically controlled 
MEMS device that utilizes an external magnetic field to deform an internal membrane 
that increases reservoir pressure and triggers drug release 
85
. Yim and Sitti developed a 
compliant magnetic capsule to be used for drug delivery in the stomach 
86
. The device is 
actuated via magnet induced rolling and could release the drug when an external magnet 
is moved close to the capsule. In 2013, Woods et al developed a capsule that loaded a 
rotatable drug injection needle and performed a localized drug injection with the help of 
another position feedback system 
87
. At present, no significant improvement of the 
volume utilization has been achieved with the external magnet actuated drug release, but 
there have been advances in release flow rate control and multi doses injection 
88
. Besides 
the mechanical release approach, several novel release systems that diffuse the drug 
owing to the physicochemical properties have also been developed. For example, drug 
chemical interactions that are triggered in response to certain conditions of the 
environment were studied in a colon targeting experiment 
78
. Driving the drug through its 
magneto-hydrodynamic property also showed promising results in in vitro validation 
89
. It 
is a release system that is driven by the drug’s physicochemical properties and has the 
potential to increase the drug loading capacity but also shows drawbacks in precise 
control of the dosage and release rate 
90
. 
The most significant disadvantage of the current drug release system is that there 
is no reliable long-term attachment implementation. There is no guarantee of holding the 
capsule at a specific location while activating the release mechanism. The capsule will 
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move forward upon the activation of the drug release mechanism and pose a significant 
safety problem.  Additionally, remote actuation for multi-dose release and controlled 
flow rate are still challenging. Owing to its ability to reach the area where normal 
interventional procedures have no access, drug delivery through capsule robot will keep 
thriving in future 
91
.  
Besides drug delivery, tissue manipulation technique to conduct biopsy or 
therapeutic intervention is another area for the potential application of the CR. The first 
intestinal biopsy capsule, reported in 1957 operated by sucking in the intestinal tissue 
then cutting it off through a spring actuated blade 
92
. In last two decades, biopsy capsules 
were still being developed following the same principle 
93–95
. In addition to biopsy, 
capsule robots which can perform small surgeries through tissue manipulation tool were 
studied by several groups. Valdastri et al developed an interventional surgical clip 
capsule that can target lesion site via an external magnetic arm and clip the tissue. This 
prototype was tested in vivo and proved feasible 
96
. Ryou et al introduced a method to 
create a gastric anastomosis via self-assembling magnets on capsule endoscopy. Those 
magnets worked as laparoscopic graspers to grasp the tissue walls. This concept has been 
tested in porcine and human cadaver trials 
97
. Interventional therapeutic approaches 
through capsule are highly dependant on the tissue localization and manipulation function 
that usually can be found in the locomotion or attachment systems. Nearly all research 
that works on therapeutic capsules also involves a certain type of active locomotion or 
attachment system development. The rapid progression of the locomotion and attachment 
systems of CR shows a broad perspective for the development of capsule therapeutic 
techniques.  
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1.3.4 Interactions model between capsule robot and GI tract 
It’s almost impossible to design an excellent active CR without the awareness of 
the mechanical properties of GI tract 
98
. Nowadays, the iteration of capsule locomotion 
and drug delivery system all suffer from the insufficient on-board battery power and large 
volume occupancy by the power supply component, so promoting the energy efficiency 
of a CR has long been the top concern of the capsule design. The interaction between the 
CR and the GI tract can be complex. It involves deformable boundaries (tissue), non-
Newtonian fluid (chyme), periodic load (intestinal peristalsis), and anisotropic, multilayer, 
viscoelastic soft tissue. It is almost impossible to build a theoretical model that describes 
the whole interaction and predicts the behaviors analytically due to the above properties. 
Despite all of this, insightful results still can be obtained if the quantification is only 
focused on the effect of some key factors. The friction is such a factor that affects the 
CR’s passive moving speed and the capacity of passing the narrow lumen area. In 2007, 
Kim et al developed an analytical frictional resistance model for the development of 
capsule endoscopes in the small intestine 
99
. Capsule weight, stress due to tissue 
deformation, and peristaltic contractions were considered as variables. They suggest that 
the frontal shape of the robot was a major contributor to the frictional resistance. Wang et 
al conducted an experiment to measure the resistive properties of the small bowel in 2010 
100
. They found that the capsule’s size and moving speed affect the amount of resistive 
(traction) force experienced. This traction force may be as high as 8 times the magnitude 
of a capsule’s weight and partially validate Kim’s theoretical model. Since building such 
a comprehensive theoretical model is so difficult, the finite element method (FEM) is a 
possible solution. It is superior in dealing with large deformation, complex boundary 
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shape and multiphase problems (solid-fluid). To build FEM model, the first step is 
always properly defining the materials. Obtaining the mechanical property of the capsule 
is not difficult, but for soft tissue, it can be challenging. In 2011, Terry et al quantified 
the radial (contact) component of peristaltic forces generated by the contractions of the 
mutually orthogonal circular and longitudinal bowel lumen muscle layers 
101
. The group 
developed a migrating motor complex force sensor (MFS), a biaxial stress/strain 
apparatus, an in vitro mucous adhesivity protocol, and an in vivo tribometer. The 
characterization of the small intestine tensile behavior precisely described the 
hyperelasticity of tissue and could assist in the material definition.  
 
Fig.1-4 Biaxial test apparatus and mounted intestine sample 
101
. 
In 2006, Kim et al derived a five-element model to represent the stress relaxation 
of the small intestine that could describe its time-dependent behavior 
102
. Wang et al 
validated Kim’s work by comparing various form of small intestine viscoelastic models. 
They suggested that the five-element model family with a Double Maxwell-arm Wiechert 
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(DMW) representative model was the best choice for its mathematical simplicity and 
experimental fit accuracy 
103
. 
Having accurate materials properties doesn’t mean the FEM model can be easily 
built. State-of-the-art FEM simulation of CR can be only found in several limited 
applications including the stress distribution in the tissue along a capsule 
104
 and magnetic 
field distribution from an external magnet 
105
. It has been difficult to accurately determine 
the loading conditions and boundary constraints. None of the models can simulate the 
complex interaction that occurred in the locomotion or attachment process, and no model 
considered the solid-fluid multiphase condition in the GI tract. Our previous work 
developed 2D and 3D model to simulate the situation where the tissue was aspirated into 
the capsule. Those models could guide us to optimize the geometry of the corresponding 
mechanism but the significance was limited due to the missing of tissue damage 
properties 
106
. 
The CR research at present is more like an experiment-driven work than anything. 
The theoretical model which has universal guiding significance to the CR development is 
missing, though a massive effort has been devoted to the modeling. With the progress of 
numerical multiphase coupling technique and more simplified tissue fracture model, we 
expect further improvements in coming years. 
1.4 The aim and scope of this work 
The rapid evolution of CR technique, which went from being an image recording 
tool to being capable of controlled locomotion, target attachment, drug delivery and 
tissue manipulation, can be clearly seen from these selected studies. The market for smart 
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CR was expected to grow to $1 billion by 2017 
28
.  Today, any evolution of the non-
invasive gastrointestinal diagnosis procedures must rely on the progress of at least one 
CR techniques. The device we present in this thesis is an implantation capsule robot 
(ICR). This ICR is a swallowable size (similar to the commercial CE) robot and a 
spreadable tissue attachment mechanism (TAM) as subsystem, which could anchor to the 
intestinal wall long-term and an ejection mechanism to allow the TAM be launched from 
the ICR. The ICR body will separate from the TAM and be expelled from the GI tract. In 
our vision, biosensors for accurate in situ monitoring and large volume drug release 
systems can be further integrated on the TAM and implanted to the target area of GI tract 
through the ICR. As can be seen from the above discussion, the main drawback that the 
current CR faces is that it cannot maintain its position for a long period in vivo. Long-
term attachment is considered the fundamental requirement for comprehensive in vivo 
monitoring and long-term drug release functions. The standard CE can only stay in the GI 
tract for a couple of hours, this short time window limits the quanity of bioindices (pH, 
temperature, pressure) to be gathered in vivo. It also sets an obstacle for the study of long-
term drug/nutrition absorption. If physicians could monitor the GI tract in longer time 
manner, crucial bioindices variation can be built in a certain time period; more accurate 
diagnosis can be made especially of the chronic digestive disease. The long-term drug 
release system can improve the effectiveness and convenience by reducing the CR retake 
times, and provide opportunities to analysis the long-term effect of drugs. 
Through this work, we address some of the challenges of current CR and hope 
that our verified results could provide inspirations to accelerate the evolution of non-
invasive CR technique. In this dissertation, Chapters 2-4 contain the majority of our 
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design and validation procedures. We first recount the inspirations we gathered from 
nature, which later helps us design the TAM. Then various in vitro and in vivo 
experiment are performed and presented to verify the efficacy and safety of this device. 
Chapter 5 is the preliminary FEM modeling of this device.   
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CHAPTER 2. INSPIRATION OF NATURE: ATTACHMENT PROCESS AND 
STRENGTH OF PARASITE 
2.1 Background 
In recent years, the morphology, corresponding motion, and adhesion mechanism 
of a wide variety of parasites have attracted interest among researchers in various fields 
107,108
. In general, intestinal parasites maintain their position either by active movement 
within the mucosal layer (e.g. pinworm), attachment to the intestinal surface using 
“adhesion pads”, structures acting as a wedge or anchor (whipworm), rigid hooks 
(thorny-headed worms and many tapeworms), or clamp-like structures formed either by 
the stoma (several group of nematodes) or muscular pads configured as round cup-shaped 
suckers (tapeworms and trematodes) or elongated pads with grooves (cestodes of the 
family Tetraphyllidea). While tapeworms (Cestoda) can utilize a variety of attachment 
methods 
109,110
, species in the order Cyclophyllidea use either suckers, rostellar hooks, or 
a combination of both (Fig. 2-1B) 
110,111
 to attach the scolex to the intestinal wall. 
Attachment solely by suckers allows parasites to move along the GI tract freely with 
reattachment causing minimal or no apparent tissue trauma.  
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Fig.2-1 Microscopy images of the parasites with suckers and hooks. A) scolex of H. 
diminuta used in the test, showing three muscular suckers with an average diameter of 
86.7 μm. B) Scolex of Taenia pisiformis with a combination of hooks and suckers. 
The various attachment methods also provide vivid examples for researchers who 
are dedicated to developing actively propelled gastrointestinal medical devices for 
application in vivo. Medical robots, inspired by worm-like parasites, have been proposed 
as devices that could move successfully through the intestine 
38,112
. While successful in 
vivo movement has been realized by several medical devices, there is still no perfect 
solution for long-term attachment of those devices 
113
. If the long-term attachment of 
biosensor or biomedical devices could be achieved, physicians could continuously 
monitor a patient’s physiological indices (like core body temperature, pH, and pressure in 
the GI tract) and make more accurate diagnoses. In addition, long-term attachment of 
these devices could enable novel approaches for slow-release and (or) time variable drug 
delivery, or even the ability to manipulate nearby tissue to perform microsurgery 
114
. 
Artificial hooks inspired by those that occur on the rostellum of the scolex of 
Taenia solium have shown a remarkable ability to adhere to biological substrates 
115
. An 
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attachment mechanism for swallowable robotic capsules using needles to successfully fix 
sensors to a pig’s GI tract for six days was developed in our previous work 76. Despite 
implementing the attachment mechanism from small diameter needles, these hooks still 
penetrate into the mucosa and may cause minor tissue damage and subsequent 
inflammation. 
Certain species of tapeworms can attach to the GI tract of vertebrates for an 
extended time-period without creating any noticeable damage to the host due to their 
“non-penetrative” attachment mechanism and the relatively small geometry of the scolex. 
This type of attachment raises some research questions. How does the very small scolex 
support and sustain the whole body against forces from peristalsis and liquid flow of the 
GI tract? What is the exact attachment strength of the parasite? To the authors’ 
knowledge, these questions have not been answered in the literature. To better understand 
the attachment process and replicate the structure of the attachment mechanism, a method 
to measure the attachment strength of a parasite was designed, and the attachment 
strength of a series of individuals of H. diminuta was measured. 
Hymenolepis diminuta, also known as the rat tapeworm, unlike many other 
closely related species including Vampirolepis nana and V. microstoma, uses only four 
suckers to clamp on the mucosal villi of the intestine to maintain its position in the gut 
(Fig. 2-1A). In addition, the scolex of individuals of H. diminuta parasitizing rats 
regularly detaches and re-attaches to new sites in the intestine 
116
. In the permissive host, 
while some inflammatory response has been observed 
117
, no localized tissue damage 
occurs. 
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2.2 Method 
Beetles (Tenebrio molitor) infected with larvae of H. diminuta were purchased 
from Carolina Biological Supply and the cysticercoids were fed to twelve laboratory rats. 
Due to the exploratory nature of the investigation and the lack of published protocols, the 
12 rats were divided into 3 groups and infected with a varying number of cysticercoids. 
Individuals in group one were infected with 2-3 cysticercoids; group two with 4-6 
cysticercoids, group three with 7-12 cysticercoids. Three weeks after infection, fecal 
pellets were checked for the presence of tapeworm eggs, and the second phase of the 
experiment started. Individual rats were euthanized following standard Institutional 
Animal Care and Use Committee (IACUC) recommendations: carbon-dioxide exposure 
until breathing stopped and followed by cervical dislocation. The use of a general 
anesthetic agent (isoflurane) was deliberately avoided to prevent interference with 
tapeworm attachment. Immediately after rats were euthanized, the small intestine was 
removed and placed in room temperature Hanks saline solution to prevent immediate 
tissue degradation. Starting from the duodenum, the small intestine was opened in small 
segments, until an attached tapeworm was found. Intestinal tissue surrounding the 
attachment site (approx. 10mm on each side) was exposed and removed. Part of the 
intestinal tissue along with the strobilated body of the tapeworm (usually 50-100mm) was 
moved to a smaller petri dish containing Hanks saline solution (Fig. 2-2A). 
The basic idea to test the attachment strength of H. diminuta to the small intestine 
of the rat was to pull the tapeworm vertically when it was attached to intestinal tissue 
placed horizontally in a petri dish and to measure the force required to detach the 
tapeworm. In this work, a tensile test machine (ADMET eXpert 5601, ADMET Inc.) and 
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a digital scale (Denver Instrument XE-50) were used to measure the attachment force of 
H. diminuta. The accuracy of the load cell on the tensile test machine is 0.01N and, based 
on the authors’ first experiment, it exceeds the range of the attachment strength of 
tapeworms. To solve this problem, a digital scale with a resolution of 0.0001g (10-6 N) 
was used to calculate the exact attachment strength (see Fig. 2-2 B for experimental 
setup). 
 
Fig.2-2 A) Image of the removed tissue with attached H. diminuta. B) Schematic 
arrangement for testing the attachment strength of H. diminuta in the rat intestine using a 
tensile mechanism and digital scale. 
The petri dish containing the intestinal tissue and the attached tapeworm was 
placed on a pre-zeroed digital scale at the base of the tensile test machine. The strobilate 
part of the tapeworm was looped on a hook which was mounted on the tensile test 
machine’s grip. Preliminary tests also showed that the attachment force of this worm was 
small compared to the weight of the tissue and the liquid surface tension, so there was no 
need to immobilize the intestinal tissue. The initial value of the scale was recorded as the 
starting point, and the tapeworm was pulled away from the tissue at a rate of 1mm/sec. A 
digital camera recorded the entire process and tracked all scale readings. 
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As the tapeworm was pulled, the reading on the scale decreased and achieved a 
minimum value right before the tapeworm detached from the tissue yielding the 
attachment strength as calculated in Eq.2-1. 
Attachment strength = Initial scale reading – Minimum scale reading                        (2-1) 
2.3 Results 
Rats that were exposed to a low number of cysticercoids were inadequate subjects 
for the intended experiment. Two out of the four rats that received 2-3 cysticercoids did 
not get infected in the first attempt and needed to be re-exposed to larval tapeworms. 
Tapeworms in low-intensity infection (1-3 tapeworm/host) showed different distribution 
and behavioral pattern than tapeworms in more crowded (5-12 individuals/host) 
environments. When there were only a few tapeworms in the host, they tended to be 
attached to the upper part of the small intestine (approx. 5-15 mm from pyloric sphincter), 
and scoleces detached at the slightest disturbance or touch during necropsy. Tapeworm 
scoleces in a crowded environment were more evenly distributed within the small 
intestine, and they were less likely to detach during the preparation phase. The tensile 
testing process was shown in Fig. 2-3. 
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Fig.2-3 Tensile test of the attachment strength of the tapeworm. A) The tapeworm before 
detachment. B) Tapeworm detached from the tissue. 
Twelve tapeworms from four rats tested successfully for attachment force. 
Measurements varied between 0.008g (min) and 0.04g (max).  The average attachment 
strengths of tapeworms in each rat were 0.027g (SD=0.009g), 0.016g (SD=0.004g), 
0.014g (SD=0.014g) and 0.018g (SD=0.001g) respectively (Fig. 2-4, error bars represent 
the standard deviation). The measured strengths are close among replicates and no 
significant differences exist among replicates from individual rats. The combined average 
attachment strength of the H. diminuta was 0.021g (SD=0.011g).  
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Fig.2-4 Attachment strength of the tapeworms in each rat. 
The wet weight range of the worm was also measured as 0.596g-1.427g, but these 
values only provide a minimum estimate for the full weight, since the full extraction of a 
single tapeworm was not feasible while focusing on the main goal of the experiment. 
However, in general, more competition and crowding (greater number of tapeworms per 
rat host) decreases tapeworm size, both in length and weight 
118
. Several H. diminuta 
specimens extracted from the rats were relaxed in distilled water, fixed in buffered 
formaldehyde solution, stained, and mounted on microscopic slides for morphological 
examination. The average measurement of the suckers is 115.92 µm (±1.0782) in length 
and 92.49 µm (±14.239) in width. While the shape of suckers is slightly ovoid, a circle 
for further calculations using the average of length and width: 104.2 µm (Fig. 1b) is 
applied. The sucker was assumed to be hemispherical in shape, so the local force exerted 
by the suckers on the intestinal tissue could be calculated by the average attachment 
strength divided by the area of the sucker (Eq.2-2). 
Suction pressure = Attachment strength / (Area of four suckers)                                  (2-2) 
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The average attachment pressure of H. diminuta was calculated to be 6.145kPa. 
The risk of bowel perforation with the use of suction drains with a vacuum pressure of 8-
24kPa has been reported by clinical research 
119
. Since the measurements were taken 
between the outside margins of suckers on relaxed specimens, the estimate, 6.145kPa, is 
a lower estimate of the actual pressure on the host tissue. Still, the present result indicates 
that the suckers’ working pressure is at or below tissue damage tolerance. 
2.4 Conclusion 
Hymenolepis diminuta (Cyclophyllidea, Hymenolepididae) is a parasitic 
tapeworm of rats (Rattus). On rare occasions, it can infect humans 
120
, but the main life-
cycle involves insects as intermediate, and rats as definitive host. This tapeworm species 
is often used as a model organism in scientific research focusing on tapeworm biology 
due to the simplicity and safety in maintaining infected hosts. A unique feature of the 
genus is the lack of hooks on the scolex, and a very reduced rostellum called an apical 
organ in this species. This morphological characteristic is in contrast to related species, 
such as H. microstoma, a synonym of Vampirolepis microstoma 
121
, that have both a 
rostellum and rostellar hooks on the anterior end of the scolex. Vampirolepis microstoma 
with rostellar hooks appears to have a permanent attachment site in the host and the fully 
developed tapeworm does not relocate in the intestinal tract depending on food 
availability 
122
. The hooks on the rostellum are firmly embedded into the secretory 
"crypts of Lieberkühn" at the base of the villi 
123
. 
The research interest of this paper focused on understanding the physical 
interaction between parasite attachment and host tissue. Interest in this area of 
investigation was driven by biomedical research and the need to place medical sensors in 
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the intestinal tract and to investigate attachment strength in a biological system that does 
not use hooks. As an example of such a biological system, tapeworms in the intestine 
have to counteract forces created by drag as digested food moves along the intestinal tract.  
The main finding is that attachment force of the tapeworm to the intestinal wall is 
very weak. The average attachment strength of H. diminuta was measured as 0.021g with 
SD ±0.011g. This value is only a small portion of the potential weight of an adult 
tapeworm. If we consider that the tapeworm is neutrally buoyant and only fluid drag is 
considered as the main force, scolex attachment strength alone does not explain how this 
species remains fixed in the intestine. Hymenolepis diminuta has four kinds of muscles in 
its proglottids: longitudinal, circular, transverse, and radial bundles 
124
. These muscles 
create a peristaltic movement that can counteract bowl movement. In this regard, the 
attached scolex provides a fixed starting point. In addition, the peristaltic movement of 
tapeworm proglottids is independent of movement shown by the scolex, and the 
movement is controlled by local mechanical and chemical stimuli acting on neighboring 
proglottids 
123
. The mechanism that H. diminuta uses to maintain position in its host is 
very different from other intestinal parasites. The suckers, which act more like circular 
clamps than suction pads, grab onto the intestinal villi. Because of normal growth and 
digestive processes, cells in the intestinal villi are being constantly replaced and a villus 
can be lost and regrown rapidly following damage. For this reason, the tapeworm must 
have the ability to reattach and maintain position while the scolex becomes disconnected 
from the intestinal wall. The ability of H. diminuta to detach, move, and reattach, enables 
the parasite to remain in the host for a very long time. Infection longevity is limited only 
by the host’s lifespan 125. Other parasites that lack the peristaltic movement such as 
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Moniliformis dubius (Acanthocephala), utilize hooks on the proboscis to embed and 
attach to the intestinal wall permanently and firmly. In contrast with the rat tapeworm, M. 
dubius have a shorter lifespan measured in weeks rather than years 
126
 and detached 
specimens are expelled from the intestinal tract.  
Our estimates of the force and pressure exerted by the parasite suckers on host 
tissue are close to other estimates of tissue damage tolerance 
119
. A question that the 
experiment could not address is whether one or more suckers were clamping on the 
intestinal tissue. Previous studies on tapeworms fixed in-situ for microscopic examination 
indicate that there are often two suckers clamping on the intestinal tissue 
109,123
. If only 
two suckers are involved in the attachment, the calculation of the pressure on the host 
tissue is underestimated by a factor of two and our estimates may be slightly above the 
minimum tissue damage tolerance (8 kPa). 
The significance of this research is that it could be used as a guide for biomimicry 
researchers to design and develop an in vivo tissue contactable bio-robot. The strength of 
parasites with hooks is difficult to investigate due to the lack of laboratory cultivation 
approach. 
Since the suckers in micro-scale are insufficient to provide enough attachment 
strength, the idea is jumping to meso-scale; in the next chapter the attachment mechanism 
made with a scolex-like structure of parasites and replicated in meso level is discussed in 
detail. 
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CHAPTER 3. TISSUE ATTACHMENT MECHANISM DEVELOPMENT 
3.1 Background 
The CE is one of the most common non-invasive clinical tools in the evaluation of 
GI tract disease 
127
. Currently millions of CEs have been used world-wide to diagnose the 
small-bowel and to assess GI tract performance 
128
. Specifically, CE intervention has 
been adopted when gastroesophageal reflux disease, obscure gastrointestinal bleeding, 
Crohn’s disease, and polyposis syndromes are indicated 129. Numerous clinical records 
and multiple studies have proven that CE intervention is superior to radiologic 
interventions and push endoscopy because it is non-invasive, has relatively small 
dimensions, features high image quality, and provides direct visualization of the tissue 
130–132
. After 14 years of clinical CE use, researchers are looking to expand this method 
into new domains due to increases in chronic diseases and an aging population. In the 
past, the movement of the CE was passive and a function of intestine peristalsis, but now, 
in order to complete more accurate diagnostics and treatment of chronic diseases, the CE, 
and swallowable microrobots in general, must offer controllable locomotion, long-term 
(more than a week) data collection, and drug delivery function. A variety of locomotion 
systems for CE have been developed by different methods such as shape memory alloy 
legs 
133
, magnetic drive 
134
, and earthworm-like locomotive mechanisms 
38
. However, the 
CE’s capability to acquire long-term physiological indices is limited because of its 
inability to remain attached to the GI tract in vivo long-term. The gastrointestinal wall is 
irregular, slippery, chemically corrosive, and physiologically active due to peristalsis 
135
. 
No traditional technologies enable effective adhesion to such a surface for a prolonged 
period of time without causing damage or bleeding 
115
, and premature loss of the capsule 
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during sensing periods has often been reported 
136
. Mucosal adhesive patches may be a 
potential solution for the long-term attachment requirement, as studied by several 
research groups. Dodou et al. have shown that high static friction could be created 
between a colonoscopic device and the GI wall due to mucoadhesion 
73,137
. In the work of 
Dario et al. 
113,138
, mucoadhesive patches have been tested and assembled with a release 
mechanism in the CEs. Additionally, it has been shown that with 5N preload force, 110 
min stable anchoring could be achieved for a 10 mm diameter mucoadhesive patch. 
These improvements are incremental, however, and still do not enable multi-day or 
weeks long attachment. Better clinical outcomes could be obtained if physicians could 
obtain continuous readings of the small intestine from stationary CEs. For example, 
temperature and pH of the intestine have been considered as two important factors 
influence the enzyme activity which thereby affect the digestive function 
139
. Long-term 
monitoring of these two critical values would be helpful to the diagnosis of digestive 
system diseases. Also, in addition to data collection and image recording, long-term 
attachment may provide other possible functions to CEs such as tissue manipulation and 
drug delivery 
114
. The noninvasive sustained release of antibodies to the GI tract is 
currently not possible and only available through periodic injections or invasive implants. 
The TAM mechanism could facilitate sustained release of these agents as well as the 
long-term delivery of chemicals that stimulate or inhibit growth of specific bacterial 
species in the GI tract 
140
.  
As a result of unsuccessful long-term attachment, we have investigated 
biomimicry. As can be seen in our previous work 
141
, many species of animals and 
parasites are successful in attaching to surfaces similar to the lining of the GI tract for 
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long periods of time and have been replicated by biomimicry in multiple applications 
142,143
. Based on our observations, most of these creatures, such as the leech, lampreys, 
and tapeworms, have a similar mouth structure: a combination of hooks and suckers, that 
work together to achieve the attachment function. Current research found that the firm 
attachment of parasites is mainly attributed to the hooks and the function of the sucker is 
to help in “anchoring” those hooks, resulting in a long-lasting, secure, safe attachment 144. 
In this work, a bioinspired replication of this kind of attachment structure has been 
designed, fabricated, and tested. We have shown feasibility of implementing a tissue 
attachment mechanism (TAM) on a swallowable capsule in our previous work 
145,146
. 
Briefly, to place and actuate the TAM on a carrier capsule robot (whose dimensions are 
close to the commercial capsule endoscopy), the empty space within the capsule is 
evacuated of air to create a vacuum chamber. The vacuum chamber is then connected to 
the TAM sucker through a hole which is blocked by a microcontroller-actuated wax 
valve. When the capsule reaches the desired location, a heating circuit triggered by the 
microcontroller melts the beeswax and allows the tissue to be aspirated by the vacuum 
pressure and captured by the TAM 
147
. Once the tissue is captured, the carrier capsule is 
expelled due to intestinal peristalsis. Considering the relatively small size of the TAM 
with the sensor compared to the whole carrier capsule, the risk of intestinal obstruction 
by the TAM is considered as acceptably low. In this work, the attachment mechanism has 
been optimized using an in vitro tissue adhesion experiment as well as live animal testing.  
Although this study focuses on the small intestine, the mechanism may be applied to 
other locations in the GI tract with the same slippery environment and similar material 
properties. 
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3.2 Methods 
3.2.1 Attachment mechanism design and preparation 
To achieve successful long-term attachment, the TAM should have the following 
four features and abilities: small dimensions, reliable adhesion ability, the ability to 
function without causing significant trauma, and operability that does not interfere with 
physiologic bowel function. These features are addressed in this work, in which a tissue 
attachment mechanism (TAM) was fabricated by computer modeling and 3D printing 
(Object 30 pro, Stratasys). 
The TAM has a curved surface and a hole on it (Fig. 3-1a). Around the hole, 
micro needles (Diameter 0.53mm, Clover Mfg. Co., Ltd.) were installed equidistantly at 
an angle (theta) relative to the vertical plane in an attempt to replicate the sucker mouth 
teeth. Too many needles decrease the structural strength of the TAM, so the number of 
needles was fixed at six. There are four other size parameters that could affect the contact 
performance between TAM and the tissue, which are sucker diameter D, needle array 
diameter d, needle angle θ, and needle length L (Fig. 3-1a, c). These four parameters 
were tested and optimized as described below. To realize adhesion in the test, the surface 
of the TAM made contact with the intestine wall and a vacuum pump was connected to 
the TAM via a custom connector (Fig. 3-1b). The suction created by the vacuum aspirates 
a small amount of tissue into the TAM sucker and facilitates long-term attachment by 
fixing the tissue to the needles. 
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Fig.3-1 Attachment mechanism prototype: a) Three views of the attachment mechanism. 
b) Attachment manipulation system, including the attachment mechanism, connector, and 
vacuum pump. c) Cross-sectional view of the critical dimensional variables of the 
mechanism: sucker diameter D; needle diameter d; needle angle θ; needle length L. 
The legs with holes (Fig. 3-1a: right view) were used for mounting a radiopaque 
marker for the in vivo testing of this work, and will carry a biosensor in future work. The 
current design of the TAM only focuses on the long-term adhesion function. The 
detachment mechanism will be added in the future; with the combination of attachment 
and detachment mechanisms, multi-suctions per working cycle controlled by the carrier 
capsule could be realized. 
3.2.1 Adhesion strength test 
An adhesion strength experiment was conducted to select the most suitable 
dimensions with enough adhesion ability. As shown in Fig. 3-1c, four parameters 
determine the dimension of the TAM. To avoid bowel perforation, a needle length was 
specified to be shorter than the thickness of the tissue. In this work, 2 mm was chosen for 
the needle length because this is less than the maximum expected thickness of the small 
intestinal tissue 
148
. Among the remaining three parameters, sucker diameter and needle 
angle were chosen as the independent variables, and when these two variables have 
certain values, the last parameter, needle array diameter, is determined. In this test, five 
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different sucker diameters (from 3 mm to 7mm) and three different needle angles (30°, 
45°, and 60°) were chosen as size variables which provided fifteen different TAM 
configurations. These fifteen TAMs of different size parameters were tested to evaluate 
their adhesion ability in vitro. Fresh porcine intestinal tissue was obtained from Elmwood 
Meat Plant in Elmwood, Nebraska. Vacuum pressure of 635 mmHg (the desired 
maximum pressure to aspirate enough tissue via these TAMs) was reached within 2 
seconds to aspirate a rectangular piece of tissue (approximately 40×50 mm) into the 
capture mechanism. The risk of bowel perforation with the use of suction drains with 
vacuum pressure of 60-180 mmHg has been reported by clinical research 
119
. But in our 
case, the vacuum only exists for a couple of seconds in order to aspirate the tissue, 
compared to the long working period of suction drains (5 days at least) in the literature. 
Thus, the risk of bowel perforation here was considered as acceptably low and the 
following perforation test also confirmed this assumption. The tissue was then fixed in a 
tank with saline at body temperature. The TAMs were connected to a tensile test machine 
gripper (ADMET eXpert 5601, ADMET Inc.). A speed of 10 mm/s of the crosshead was 
selected to pull the TAMs. Each TAM was tested three times on different locations of the 
tissue. The critical shear detachment force (i.e., traction force) was measured for each 
trial, and mean values for each configuration were computed. The configuration which 
most firmly adhered to the tissue was considered optimal. The results were used to select 
the suitable size of the TAM for the following test. 
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3.2.3 In vitro adhesion damage test 
One of the primary concerns for this attachment mechanism is whether it will 
cause unacceptable damage to the intestinal tissue. An in vitro tensile test was conducted 
to test the initial damage of the attachment mechanism (Fig. 3-2). 
 
Fig.3-2 a) Adhesion test system: Tensile test system. b) Schematic of the system: 
buoyancy will be offset by gravity in this case; pull force replicates the traction force of 
human intestine. 
Six TAMs with different dimensions were adhered to rectangular pieces of fresh 
porcine proximal intestine tissue (approximately 40×50mm, stored in saline at 4°C) via a 
pump with 635 mmHg vacuum pressure. The TAMs were then connected to the grip of a 
tensile test machine (BOSE Electroforce 3200 instrument, BOSE Inc.). The tensile test 
system was used to apply sinusoidal pull force, which has a peak value 0.4N and lasts 6 
seconds for each cycle (close to the maximum human intestine traction force 
149
 and 
peristalsis frequency 
150
). The TAMs were immersed into saline during the entire test, and 
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the volumes of the mechanism were calculated to make sure the buoyancy force offsets 
the weight of the TAM. Thus, the pull force closely replicates the maximum expected 
human traction force. The test lasted 10 minutes for each sample. Six TAMs with 
different critical sizes were tested. Each sample was tested on three different proximal 
intestine tissue samples. The tissue was carefully removed from the mechanism, and the 
images of the tissue surface were taken by camera. 
3.2.4 Perforation identification test 
Perforation of the bowel is a serious and life-threatening problem and may be 
caused by the needle attachment; therefore, a test was performed to assess perforation 
risk of the device. A bubble leakage experiment was conducted to test if there was any 
perforation of the tissue.  
The test setup is shown in Fig. 3-3. During the test, target tissue was fixed to the 
test device, and then a syringe was introduced to create pressure. Tissue with holes 
caused by deliberate needle perforation was used as the control. The same pressure that 
caused bubbles to appear on the controls was used to show if perforation occurred in the 
test tissue. 
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Fig.3-3 Bubble leakage test setup. a) Test devices arrangement: syringe, pressure sensor, 
test chamber and NI DAQ board. b) Control tissue sample with hole shows bubble. c) 
Test sample showing no leak.    
Based on the adhesion and perforation tests, one specific configuration for the 
TAM was selected for the animal test.  
3.2.5 Animal test 
All animals received humane care according to the Guide for the Care and Use of 
Laboratory Animals prepared by the U.S. Department of Health and Human Services and 
published by the National Institutes of Health (NIH). The study was approved by the 
University of Nebraska-Lincoln’s (UNL’s) Institutional Animal Care and Use Committee 
(IACUC, Protocol No. 887). To investigate the actual attachment duration in vivo, two 70 
kg crossbred, neutered, domestic pigs were selected for this study. Four TAMs (5mm 
sucker diameter, 45° needle angle) were placed in the duodenum of each pig with 635 
mmHg vacuum through individual longitudinal enterotomies spaced approximately 15 
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cm apart. Every sample carried a radiopaque marker (15mm in length, 3mm diameter 
stainless steel rod). This marker served two purposes. First, it represented the mass of the 
simulated sensor, which could be applied to this attachment mechanism in the future. 
Second, it enabled tracking migration of the TAM from the implant site. Each enterotomy 
was closed with a 2/0 PDS (polydioxanone) suture in a simple continuous pattern, and 
another radiopaque marker was attached to the mesenteric border at the location of each 
attachment mechanism (Fig. 3-4).  
 
Fig.3-4 Attachment mechanism and radiopaque marker placement: a) Placement of the 
attachment mechanism and the inside radiopaque marker. b) Placement of the outside 
radiopaque marker. 
Ventrodorsal (VD) and lateral abdominal radiographs were taken prior to 
recovery to verify placement of the attachment mechanism and mesenteric markers 
(Bowie PRX-90, Bowie International). The pigs were allowed to recover in a small pen 
and remained there until they were standing. Upon standing, the pigs were moved to a 
special radiographic restraint pen. Lateral and VD abdominal radiographs were obtained 
there. For the first pig (Pig A), the radiographs were repeated each hour to show if there 
was corresponding movement between the intraluminal and extraluminal markers. During 
44 
 
this period the pig did not have access to food. The pig was euthanized after 24 hours of 
implantation and tissue from the implantation site was collected for the initial trauma 
identification. For the second pig (Pig B), the radiographs were repeated each day to 
show the maximum adhesion duration of the implanted TAM. During this period the pig 
was allowed to have food. The animal was observed once daily by trained veterinary staff 
for signs of discomfort, fever, and loss of appetite as indicators of complications from the 
TAMs. The pig was euthanized after all TAMs detached from the intestinal wall, and 
tissue samples where the TAMs attached were collected for the trauma analysis and the 
perforation identification test.  
3.3 Results 
3.3.1 Adhesion reliability test 
The first discovery of this experiment is that the TAMs worked successfully only 
in a certain size range; too large or too small of a sucker diameter created poor adhesion 
which would not result in needle attachment to the tissue. More specifically, TAMs with 
sucker diameters bigger than 6mm or smaller than 4mm couldn’t realize the desired 
attachment function. The reason for this phenomenon is shown in Fig. 3-5.  
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Fig.3-5 Three different types of the attachment failure: A) Large sucker diameter. B) 
Small sucker diameter.  C) Small needle angle. 
To make a successful attachment, a large vacuum is required for a large sucker 
diameter so that it can aspirate sufficient tissue with which to attach. Therefore, under 
certain vacuum pressures, the mechanism with a large diameter makes attachment 
difficult on the side wall of this mechanism. On the other hand, the needles tend to block 
the aspiration hole if too small a diameter sucker is used (Fig. 3-5b). The tissue wasn’t 
able to be sufficiently aspirated into the chamber to allow needle attachment. Also, when 
a small needle angle was applied (close to 30°), the assembly position of the needles was 
too close to the sucker’s edge (Fig. 3-5c), which caused the structure to break during the 
fabrication process.  
Based on this observation acquired in this test, two different angles (45° and 60°) 
and three different diameters (4, 5, 6mm), totaling six combinations of the TAM 
configurations, were tested for their adhesion strength. The results are shown in Fig. 3-6. 
The first number of the sample’s name in the figure legend is the sucker diameter in mm 
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and the second number is the needle angle (e.g., 4-45 indicates a 4 mm diameter sucker 
with 45° needle angle). 
 
Fig.3-6 Adhesion strength of six TAM configurations: A) Typical force trends in TAM 
detachment process. B) Average attachment strength of each TAM configuration, data 
analyzed using a one-way ANOVA (*P<0.05) by software SPSS 19 (Chicago, IL) . 
Sample 5-45 showed both the highest maximum force value and average force 
value of 8.09 N and 4.54 N respectively and there is a statistically significant difference 
between the 4 mm group samples and the 5 mm ones. In this test, TAMs with 45° needle 
angle have better performance compared to 60° ones. The reason is that smaller needle 
angle has deeper tip position, and deeper needle tip position allows more tissue to be 
aspirated into the vacuum chamber which increases the chance of contact and attachment 
between needles and tissue. 
Vacuum clamping of medical devices without needles has previously been 
performed in the minimally invasive HeartLander surgical robot. With the aid of 
microfiber adhesive layers, Patronik et al. have shown that a vacuum clamping system 
with 26 mm
2
 sucking area could provide the average adhesion force around 1.3N 
151
. 
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With the assistance of a needle attachment array in our case, the mean adhesion force 
increased 250% with a 25% decrease in sucking area.  
3.3.2 In vitro adhesion damage test 
Each TAM was tested in three different proximal intestine samples in this test. No 
surface damage was seen by the naked eye or via microscope (40x magnification) after 
10 min adhesion with 0.4 N cyclic force waves.  
Shown in Fig. 3-7c was the cyclic force wave that was applied to the tissue. The 
drift of the displacement was the result of the non-linear viscoelastic properties of the 
tissue. With repeated loading cycles, the displacement curves shifted upward with tissue 
elongation, thus the tissue tester crosshead had to move a greater distance to provide the 
same force. By repeated loading, eventually steady state is reached at which no further 
drift occurs unless the cyclic loading routine is changed. In this state the tissue is said to 
be preconditioned 
152
. In this test, the relatively small attachment area and force made the 
test not like a complete uniaxial tensile test; the time to reach steady state is much longer 
compared to the normal soft tissue uniaxial tension test and still not reached at the end of 
the test. No visible damage was seen on any tested sample as illustrated by the typical 
image of the test tissue before and after the experiment (Fig. 3-7a, b). This result may 
suggest that the damage from this attachment mechanism is acceptably low. To further 
verify safety, however, tissue samples from this test were next tested for perforation. 
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Fig.3-7 Images of intestine wall a) before and b) after 10min adhesion test and the c) 
cyclic force wave setting. 
3.3.3 Perforation identification 
The pressure to cause observable bubbles on the pre-perforated control tissue 
sample was 6.5-8 mmHg. Thus, 8 mmHg of pressure was used to determine if there was 
perforation of the tested tissue. Fig. 3-8 shows the custom device we created for the test 
as well as the test results. None of the test tissue leaked bubbles under 8 mmHg of 
pressure in this experiment.  
 
Fig.3- 8 Bubble leakage test results: A) Test schematic.  B) Control sample shows a 
bubble leak from perforation.  C) Test sample showing no leak. 
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Furthermore, based on the authors’ observation, only a short part of the tip on the 
needles would penetrate into the tissue during the attachment process. Because the whole 
length of the needle is similar to the thickness of the intestinal tissue, the tip attachment 
wouldn’t theoretically cause any perforation. The actual experimental results also 
confirmed this. According to the in vitro adhesion strength results, the 5-45 configuration 
was selected as the test sample for the animal test due to the best attachment strength.  
3.3.4 Animal in vivo test 
Based on the results we obtained in the above step, a 5mm diameter aspiration 
hole with 45° degree needle orientation was chosen as the best size for the in vivo test.  
Lateral abdominal radiographs of pig A from the right side to the left are shown in 
Fig. 3-9. The small white rods (in white dashed box) are the radiopaque markers. Image 
A (taken before recovery of the pig) demonstrated the initial positional relationships of 
each marker. After recovery, the locations of those markers shown in the next four 
images changed slightly due to the movement and actions of the pig. Comparing the last 
three images (b, c, d), the positional relationships between the corresponding markers 
were always consistent. This result indicates that no migration of the TAM occurred and 
that the attachment mechanism adheres to the intestinal wall firmly and did not detach 
after six hours of adhesion. 
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Fig.3-9 Lateral abdominal radiographs of a pig with four attachment mechanisms in vivo. 
After 24 hours of adhesion, the pig was euthanized and the intestine was excised 
for analysis. The intestine images taken at that time are shown in Fig. 3-10. The condition 
of the serosa (the outside of the intestine) (Fig. 3-10a) at the TAM attachment site was 
undisturbed and no trauma or damage was observed with the naked eye. All four TAMs 
still adhered to the intestinal wall firmly after excising the small intestine.  The results 
indicated that the attachment mechanism could adhere to the small intestine wall 
successfully for at least 24 hours of a fasting pig and will not cause visible damage to the 
tissue surface. 
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Fig.3-10 Attachment mechanisms after 24 hours adhesion. 
As can be seen in Fig. 3-11, for the duration test on Pig B, one TAM may have 
detached at Day 3, but the other three TAMs remained in their initial position to Day 6. 
At Day 6, based on the radiographs, all TAMs move separately toward different 
directions. The effective attachment duration could be considered as six days. The pig 
had free access to food and water and maintains normal body temperature according to 
the measurement by veterinary staff during this test. 
 
Fig.3-11 Lateral abdominal radiographs of a pig with four attachment mechanisms in 
vivo 
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After seven days of adhesion, the pig was euthanized and the intestine was 
excised for analysis. No damage could be seen from both outside and inside surfaces of 
the target proximal intestine tissue. Perforation identification test confirmed this 
observation. The thickness of the intestinal wall where the TAMs were attached was 
measured by digital calipers and found to be 2.5 mm, which is thicker than the normal 
maximum thickness of the intestine wall (2mm). Future work will more rigorously 
measure and quantify the macro- and micro-structural impacts of the TAM on the tissue. 
If the tissue is indeed thickening as a result of TAM placement, as this measurement 
suggests, this phenomenon is very similar to the vascular smooth muscle cell (SMC) 
proliferation caused by stent implantation, a normal wound healing response in  which 
the cells react to the stimulation from TAM attachment and injuries from the needle 
adhesion and implantation surgery 
153
. SMC proliferation provides a possible explanation 
to the simultaneous detachment of TAMs: the intestine wall thickens and pushes those 
TAMs out of the surface, so three TAMs detach simultaneously when the intestine wall 
thickens to a sufficient thickness. This also raises a new considerable challenge for 
achieving long-term adhesion: how to deal with the bio-responses that come from the 
host. Even though there is no apparent superficial damage or perforation to the tissue, 
damage to the muscle layer due to the possible penetration by the needle tip end effector 
is also considered to be a limiting safety issue 
154
. The effect of the attachment 
mechanism on enteric deep tissue layers must be investigated by histology in future work.  
3.4 Conclusion 
A biomimetic intestinal lining attachment device has been designed and fabricated 
using 3D printing. Its adhesion ability has been tested, and the critical dimensions of this 
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mechanism have been optimized based on the results. The in vitro attachment tensile test 
verified that the initial damage caused by the attachment process did not perforate the 
tissue and showed no signs of visible superficial damage to the naked eye and microscope. 
The animal studies confirmed the reliability of this mechanism design in vivo and 
demonstrated preliminary feasibility of long-term adhesion to the GI tract by a capsule 
robot. With the developed TAM, the next chapter will discuss the development of the 
implantation platform used to deploy the TAM automatically. 
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CHAPTER 4. DESIGN AND VALIDATION OF THE IMPLANTATION CAPSULE 
ROBOT 
4.1 Background 
In recent years, bio-sensing has seen increased demand in the medical field 
155
. 
These sensors can be used to detect a wide variety of health-related biometrics such as 
body temperature or heart rate 
156,157
. Many of these biosensors are worn externally and 
thus may interfere with the lifestyle or occupation of the wearer or lack the ability to 
continuously monitor the patient for long periods of time in all environmental conditions. 
A continuous, completely non-invasive in vivo system for gathering bio-indices could 
overcome these limitations and may also lead to quicker and more accurate diagnoses of 
complex chronic diseases 
158
. There is a current need for a biosensor that is non-invasive, 
continuously monitors the desired metric over a long time period, and does not restrict 
movement or lifestyle. Researchers have recognized this need and are now developing 
“disappearables”—miniature sensors and actuators that are hidden on the body or in 
natural orifices 
159–161
. In addition to solving the problem of sensor miniaturization, two 
additional questions associated with disappearables are: 1) how to noninvasively attach or 
implant the biosensor, and 2) how to make the biosensor attach to its target position long-
term (at least one week) without causing serious trauma.   
While research on biosensors is prevalent, development in the field of capsule 
robotics has been increasing as well and might offer insight into the problem of long-term, 
non-invasive biosensing. Capsule robots have been an intense area of research since the 
introduction of wireless capsule endoscopy in 2000 
18,162
 and much has been done to 
further this technology, such as providing active locomotion to move the capsule against 
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peristaltic forces of the intestine 
53
. Recently, swallowable capsule technology has moved 
beyond simple passive traversal and diagnostics and has expanded to include controlled 
locomotion, long-term adhesion, drug delivery and biopsy 
163,164
.    
Here we leverage the widely accepted, non-invasive swallowable capsule 
technology in order to implant and attach a micro-biosensor anchor to the inner lining of 
the small intestine for the purpose of creating a general platform for delivering many 
generic, long-term, disappearable biosensors. This work will lead to our ultimate goal of 
using the gastrointestinal (GI) tract as a location for long-term biosensing and control 
applications. Doing so may enable invisible, unobtrusive, long-term physiological 
monitoring to address the problem of infrequent, clinic-based measurements. The GI tract 
is an ideal location for miniature biosensing systems due to its large volume and surface 
area, proximity to vital organs and systems, and because it is a natural pathway into and 
out of the body. 
Our approach is to create a general biosensor deployment platform that is capable 
of targeting any point along the small bowel. To do so, we are developing a swallowable 
implantation capsule robot (ICR) that performs the following sequence of events: 
An ICR is swallowed and arrives at the desired location through the digestive 
tract. 
The ICR deploys the sensor to the GI wall through the TAM. 
The ICR separates from the sensor and exits the body in a typical manner, leaving 
the sensor in vivo. 
The previous chapter presented the work focused on the design, fabrication, and 
in vitro and in vivo testing of the TAM, a subsystem of the capsule and an adhesive 
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device that anchors a bio-sensor to the mucosal and submucosal tissue long-term in vivo. 
As described in the aforementioned chapter, the TAM uses a combination of suction and 
needles to capture and grip mucosal tissue, a method that is inspired by some species of 
tapeworm which benignly adhere to the GI wall for long periods of time 
144
. A limitation 
of our previous work, however, was that the pressure used by the TAM was generated by 
a large external vacuum pump with infinite vacuum volume, i.e. the TAM was able to 
generate near-perfect vacuum for an indefinite length of time. Therefore, the in vivo tests 
required a tethered vacuum line to the TAM. That strategy was sufficient to prove the 
TAM concept; however, it is not amenable to a swallowable, capsule-based system. 
The work shown in this chapter was to design, build, and test a prototype capsule 
that accomplishes the sensor deployment capabilities of the ICR without the need for 
tethers to external components, such as a vacuum pump. Specifically: 1) An ICR sub 
system is designed that provides vacuum pressure for the TAM via a pressure vessel; 2) 
The required volume of the pressure vessel is investigated; 3) A custom microcontroller-
based circuit board is designed to actuate the TAM vacuum pressure based on an external 
signal; 4) An onboard power system is developed, and 5) The performance of the 
integrated system and its ability to capture and maintain adhesion to the mucosal tissue is 
evaluated both in vitro and in vivo.  
4.2 Methods 
The approach of this work was to design, build, and test a prototype that 
accomplishes the sensor deployment capabilities of the ICR. The design was based 
partially on bio-inspiration and also on our knowledge of commercially available 
swallowable capsules used for diagnostic endoscopy. Two of the primary requirements of 
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the ICR are transporting the biosensor to its ideal position in the intestine and attaching it 
to the intestine wall firmly for long-term monitoring. For the latter, tapeworms and other 
organisms that employ a strategy of mechanical adhesion to the soft tissue via the 
combined use of hooks and suckers inspired the design. Previous work provides details of 
these bioinspired features 
76,141,146
, and a component on the ICR called the TAM has been 
designed and optimized and consists of a sucker and a needle array around the sucker. 
During the attachment process, tissue is aspirated by the sucker and then fixed via 
needles. Once the TAM is integrated into the ICR, it can be used to benignly and 
noninvasively attach a variety of biosensors to the GI wall. Various tests were conducted 
during the design process to further optimize the performance of the TAM, the capsule 
body geometry, and the biosensor deployment function. The ICR was also functionally 
tested both in vitro and in vivo. 
4.2.1 Functional requirements 
In order to deliver a long-term in vivo GI biosensor, three fundamental 
requirements of the ICR are: 1) The ICR must be able to deploy and firmly attach the 
sensor to the wall of the GI for at least one week; 2) The ICR must successfully separate 
from the TAM and sensor once it has attached; and 3) The ICR must exit the GI in the 
typical manner. Because the focus of this work is on the delivery and attachment systems 
of the ICR, a sham biosensor is used. Ongoing work is focused on the development of 
specific biosensors that will be carried by the ICR, such as those that measure pH, 
temperature, pressure, etc. Ongoing work is also focusing on a capsule subsystem and 
method that will be used to enable the ICR to utilize wireless communication and various 
position-enabling sensors to monitor the capsule’s posture and location, and pressure of 
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the tissue on the capsule. The keys to successful attachment are knowledge of capsule’s 
location and intimate contact of the TAM with the tissue. The future sensor package will 
add these capabilities [17].  
Besides these three basic functional requirements of the ICR, other important 
general requirements are that it must work in an in vivo, moist environment at body 
temperature and that the length and diameter must be less than or equal to 30 mm and 11 
mm respectively, which are close to the dimensions of commercially available 
swallowable diagnostic capsules [18]. The ICR must also operate without tethering of 
any kind. 
4.2.2 ICR system architecture 
The ICR consists of three different functional components: 1) The TAM which is 
connected via vacuum pressure to the ICR; 2) An ejection mechanism which deploys the 
TAM to the GI, and 3) A capsule body with batteries and circuit designed to control the 
whole deployment process. 
4.2.2.1 ICR sensor deployment architecture overview 
The first requirement for this ICR is to properly eject the TAM and sensor 
following activation by the user. To accomplish this design requirement, the ICR was 
designed to store energy in a compressed spring, a vacuum chamber, and batteries. These 
different potentials are stored such that they are in equilibrium while the ICR is in a 
resting state. Once the tissue capturing sequence is activated, a ‘domino effect’ is 
initiated, releasing these energies in sequence to accomplish the task of attaching the 
sensor to the wall of the intestine. For ease of testing, the current ICR prototype was 
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designed to be reusable. This includes a battery compartment that can be opened so that a 
new set of batteries may be used on each test. The valve that releases the vacuum can also 
be reset externally. 
The TAM deployment system consists of the TAM itself and a corresponding 
ejection mechanism which are shown in Fig. 4-1.  
 
Fig.4-1 Exploded view of the ICR showing major components. 
The TAM is adhered to the ICR by pressure differential between the ambient 
pressure and the negative gauge pressure of the vacuum chamber. In the fabrication 
process, the control circuit and batteries are first installed onto the ICR body, then the 
ICR body, spring and TAM are moved to a custom vacuum assembly vessel that is 
equipped with an external pump to evacuate the chamber. The TAM and spring are 
further assembled onto the ICR body while within the vacuum environment to make sure 
the vacuum is introduced into the ICR vacuum chamber during the assembly process. 
This is done by means of a manipulator that traverses the wall of the vacuum assembly 
vessel via a sealed bearing. Once the assembly is complete, air is introduced into the 
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assembly vessel and atmospheric pressure outside the ICR pushes the TAM against a 
spring. The ICR body at different assembling stages is shown in Fig. 4-2. 
 
Fig.4-2 ICRs at different assembling stages. From right to left: mounted vacuum valve 
and nichrome wire; circuit board assembled; installed vacuum chamber and assembled 
ICR body without batteries. 
With a properly designed TAM surface area and spring stiffness, the atmospheric 
pressure will also hold the spring in a compressed state underneath the TAM. The ICR 
consists of three components labeled in Fig. 4-1: the TAM, the ejection mechanism, and 
the capsule body. These components are assembled and then placed inside of a casting 
mold. A mineral filled epoxy resin (EpoxAcast 650, Smooth-On) is then poured into the 
mold, encasing and sealing all electronics. Fig. 4-3 shows isometric renderings and a 
picture of the final manufactured ICR. The overall dimensions of the prototype ICR met 
all our design requirements except for the size. The prototype was 37.5 mm long and 15 
mm diameter, which exceeds the requirement by 7.5 mm in length and 4 mm in diameter. 
Future work will reduce the size to meet this requirement. 
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Fig.4-3 Integrated ICR working schematic and the real product. (a) ICR with TAM 
attached; (b) ICR after TAM has been ejected; (c) manufactured ICR. 
4.2.2.2 Electronics 
The ICR circuit consists of a PIC10F322 (Microchip Technology Inc.) 
microcontroller for logic with an operating voltage range from 1.8V to 5.5V, a transistor 
for activating the valve, an LED for providing user feedback in the form of blinks, and a 
reed switch for user input to activate the attachment sequence. The circuit diagram can be 
seen in Fig. 4-4.  
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Fig.4-4 Capsule circuit diagram. 
Note that the LED in this prototype is for the convenience of direct observation 
and proof of concept testing. In future swallowable ICRs, a telemetry system will be 
embedded to provide feedback. All of the electronics are powered by three LR932 button 
cell alkaline batteries (1.5V). The circuit diagrams for the ICR circuit are shown in Fig. 
4-5. 
 
Fig.4-5 Front and back circuit diagrams of the ICR’s internal circuit. 
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Battery life is important for ensuring sufficient time for the ICR to get to the 
correct position within the gastrointestinal tract. The PIC10F322 was chosen for its 
ability to go into a low-power “sleep mode” and wait for user input. While in this sleep 
mode, the microcontroller draws 25 μA from the batteries. This gives the ICR a battery 
life of 67 days while in this state, providing ample time to get the ICR into position 
within the small intestine.  
When power is connected to the circuit, the LED flashes two times to signal that it 
is functioning properly. The microcontroller then goes into sleep mode until the user 
passes a magnet over the reed switch, which begins another set of diagnostic blinks. 
Finally, the circuit is activated by passing the magnet over the reed switch a second time 
and the ICR begins its preset timer. Once the timer has expired, the circuit heats a 
resistive coil of nichrome wire, setting off the TAM sequence described below, and then 
goes back into a sleep mode. The control flow for this process is shown in Fig. 4-6.  
 
Fig.4-6 Control flow diagram for the ICR circuit. 
4.2.2.3 TAM ejection mechanism 
The purpose of the TAM ejection mechanism is to separate the ICR from the 
TAM such that the ICR can exit the body and leave the TAM adhered to the wall of the 
intestine. The ejection mechanism consists of a wax valve, a vacuum chamber, and a 
spring, as shown in Fig. 4-1. The wax valve is a 4.5 mm length of copper tubing (2.4mm 
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OD, 1.5mm ID) that is filled with paraffin wax (Gulfwax, 203-045-005). The melting 
point of the paraffin wax is altered using stearic acid, with a 9:1 ratio of wax to stearic 
acid, to keep its melting temperature sufficiently higher than body temperature while still 
melting easily given the limited energy supply. A nichrome wire (0.04 mm diameter) is 
wrapped eight times around the copper tube allowing it to be heated, melting the wax and 
opening the valve. The length of the nichrome wire was chosen such that the maximum 
amount of energy could be dissipated into the valve as quickly as possible. In order for 
this to happen, the resistance of the wire was found using (4-1). 
𝑃 =
𝑉2𝑅𝐿
(𝑅𝑖𝑛𝑡+𝑅𝐿)
2      (4-1) 
where P = power dissipated into the wire (W), V = battery voltage (V), RL = resistance of 
the wire (Ω), Rint = internal resistance of the batteries (Ω). V and Rint are both constant for 
a certain circuit system. Thus, for this single variable equation, the power is maximized 
when the resistance of the nichrome wire is equal to the internal resistance of the batteries. 
Based on both theoretical analysis and testing, three LR932 batteries were chosen 
to provide enough power to melt the wax in a couple of seconds after the activation of the 
circuit. 
The vacuum chamber is formed by two 3D-printed parts. Two different volumes 
of 0.25 cm
3
 and 0.35 cm
3
 were produced for testing. The vacuum volumes were 
determined through a method that will be discussed later in this paper. 
As mentioned, the spring is compressed under the TAM and held in place by the 
vacuum contained within the vacuum chamber. Once the ICR has been activated, the 
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attachment sequence (Fig. 4-7) is initiated. This sequence consists of three major steps. 
First, the wax in the valve melts and the vacuum pressure is then directly exposed to the 
tissue through the valve. Next, the ICR captures the tissue by aspirating it and fixing it 
onto the needles. After adhesion, the vacuum in the chamber decreases and the internal 
and external pressures reach equilibrium. Once equilibrium is reached, the spring 
overcomes static friction and the TAM is ejected from the ICR. Finally, the ICR is 
pushed by peristaltic force out of the intestine, leaving the TAM attached to the side wall.  
 
Fig.4-7  (a) The ICR enters the small intestine. (b) The wax valve is opened allowing the 
vacuum to aspirate the tissue through the TAM. (c) After the vacuum has dissipated the 
spring ejects the TAM off of the ICR. (d) The ICR exits the small bowel, leaving the 
TAM attached to the intestinal wall. 
The opposing vacuum and spring forces are balanced in the device so that the 
TAM remains firmly attached to the ICR until the wax valve opens. When the ICR is 
assembled, the force in the compressed spring must be less than the vacuum force to 
maintain an adequate seal, and the length of the spring must be long enough to push the 
TAM away from the ICR. Thus, the precise spring length and its stiffness are crucial. 
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With too short of a spring, not enough separation occurs between the capsule and the 
sensor plate; too long of a spring can cause the sensor plate to pop off despite a good 
vacuum seal. The force of the spring and the vacuum can be calculated according to (4-2) 
and (4-3). 
Fs = Kx                                                                         (4-2) 
Fv = P × Atot                                                                (4-3) 
where K is the spring constant, x is the spring deflection, P is the gauge vacuum pressure, 
and Atot is the combined area of the sensor plate seals. Naturally, Fv needs to be greater 
than Fs for the sensor plate to remain sealed to the capsule. Therefore, the spring 
deflection can be represented as in (4-4).  
        x <
P×Atot
K
                                                                      (4-4) 
Vacuum pressure of 94.87 kPa can be consistently achieved in the current vacuum 
system and the diameter of the seal location in the capsule is measured to be 5.5 mm. The 
applied spring was cut from a commercial compression spring (McMaster-Carr 
94125K521) with original stiffness value 1.82 N / mm and 11.5 mm length. The stiffness, 
K, of the cut spring is inversely proportional to its original length as shown in (4-5).  
𝐾 = 1.82 × (
11.5
𝐿
)                                                        (4-5) 
where L is the length of the cut spring. Since the well in which the spring sits is 
4.35 mm deep, the deflection x in (3) is therefore equal to L − 4.35. Thus, (3) is fully 
expressed as (4-6). 
(𝐿 − 4.35) <
𝑃×𝐴𝑡𝑜𝑡
1.82×(
11.5
𝐿
)
                                                 (4-6) 
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According to the calculation, the total length of the spring theoretically should not 
exceed 5.54 mm. The calculation provided a general estimation of the spring length. This 
calculated length was fine-tuned by iteratively cutting down the spring until the capsule 
sealed repeatedly for a long period of time. The capsule was able to seal reliably at a 
spring length of 7.5 mm, and it remains sealed with this spring length for longer than 5 
days. Although  Fs slightly exceeds Fv, this excess is balanced by the friction of the O-
ring in the seal sites and the spring release length of 3.15 mm (7.5 mm – 4.35 mm) is able 
to push the TAM such that it clears the ICR. The tensile normal force needed to 
prematurely remove the TAM from a sealed ICR (with a compressed spring installed) 
was measured to be 5.59 ± 0.74 N (mean ± SD) on the tensile test machine. Compared to 
the 8.79 N spring force in its compressed condition, the safety factor for premature 
separation due to spring compression force variability is therefore 1.64. This indicates 
that an unexpected tensile normal force generated by handling the capsule during 
implantation or from peristalsis must exceed approximately 5.59 N to cause premature 
separation. Forces on the capsule TAM are expected to be shear or normal compression, 
which have no effect on premature separation.  
From the in vivo experiments, we found that the ejection motion of the TAM is 
occasionally snagged by the spring resulting in a deficient release, especially when the 
irregularities of the ejection mechanism are introduced in the fabrication and assembly 
process. In addition, although the TAM ejection spring has posed no complications or 
problems during in vivo testing, future versions of the device may incorporate an alternate 
strategy for TAM ejection in order to reduce the risk of ICR retention and increase the 
deployment efficiency. 
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4.2.2.4 Tissue attachment mechanism (TAM)   
Since the aim of this research was to explore the ICR, a TAM with a sham 
biosensor was used for all tests described above. Exact geometry, functionality, and 
tissue adhesion features of the TAM were optimized and tested in a live porcine model in 
previous work. Briefly, three parameters that determine TAM geometry were varied in 
the previous study: hole diameter, needle length and needle angle. The adhesion strength 
of the TAM to the tissue was tested using the tensile testing machine. In the tests it was 
determined that a hole diameter of 5 mm and needle angle of 45° were the optimum 
needle protrusion geometry. These parameters were replicated for this study. Future work 
will include studying materials that are optimally suited to long-term contact with the 
mucosa and submucosa (316L stainless steel needle, biocompatible 3D printing material). 
Regardless of the materials chosen, because the mechanism of the TAM attachment is 
purely mechanical, we anticipate that attachment performance will be similar if the future 
biocompatible materials or coatings have similar mechanical and geometric properties. 
Also in future work, the bio-sensor will be integrated on the TAM and deployed as a 
single component. 
4.2.3 Testing 
Testing of the current iteration of the ICR was performed with the overall purpose 
of assessing the repeatability of the ICR’s ability to attach a TAM to the wall of the small 
intestine and ensure that the ICR separates from the TAM following tissue attachment. 
Note that current development is targeting the small intestine only and that all the in vitro 
tests were performed on freshly excised porcine intestine tissue. 
69 
 
4.2.3.1 Vacuum volume test 
As mentioned, vacuum pressure is used to hold the TAM onto the ICR as well as 
to aspirate tissue into the capture mechanism once the tissue capture sequence is initiated. 
The vacuum volume, which is the volume of the cavity in the ICR from which air is 
evacuated, is considered as a crucial parameter because changing the size of the vacuum 
volume affects the tissue capture dynamics by enabling more or less tissue to be pulled 
into the ICR. 
Previous versions of the ICR sought to maximize this parameter, resulting in a 
vacuum volume of 2.5 cm
3
 
146
. The entire volume of the ICR is approximately 5.5 cm
3
, so 
this is a relatively large portion of the ICR’s total available volume that is dedicated to 
vacuum. Furthermore, with such a large vacuum volume, the residual vacuum after tissue 
capture generates too large a force for the spring to push the TAM off, leaving the entire 
ICR attached to the intestinal wall, which creates an undesirable retention issue. Ideally, 
the minimum vacuum volume that still successfully captures tissue should be used as this 
leaves the maximum amount of volume for ICR components. Thus, an experiment was 
designed to determine the optimal vacuum volume. 
To determine the ideal range for the vacuum volume, a replica of the tissue 
capture mechanism was fabricated with an attached tube that could be pinched off, 
yielding varying vacuum volumes as shown in Fig. 4-8.  
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Fig.4-8 Vacuum volume test setup. ICRs with different vacuum volume chamber were 
connected to a vacuum pump; when the vacuum was created by the pump, success rate of 
tissue capture and residual vacuum pressure were recorded.  
A piece of fresh tissue (approximately 30 mm × 30 mm) was then placed over the 
TAM and captured at varying volumes. Each volume was tested three times and the 
pressure reading was averaged. A pressure transducer was attached to the vacuum 
chamber so that the pressure could be measured before and after capturing. The 
successful vacuum volume was determined by observing the tissue during each test and 
determining the smallest vacuum volume for successful and consistent tissue capture. 
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4.2.3.2 In vitro Functional Validation Experiment 
Our previous work has shown that the geometry of the TAM, specifically the 
needle length, needle angle, and sucker hole diameter, has a significant influence on the 
attachment performance, and those variables have been tested and finalized. However, 
these TAM parameters were determined by deploying the TAM manually using an 
infinite vacuum volume. Thus, an experiment was designed to investigate TAM 
functionality with other vacuum volumes. Furthermore, in previous work, the TAM was 
tested prior to the invention of the ICR ejection mechanism, so the integrated system was 
also tested. This experiment was designed to investigate the efficiency of TAM and ICR 
function in a simulated in vitro environment as a step towards in vivo testing. The ICR 
was tested intraluminally using intact, freshly excised porcine intestine.  The geometry of 
the TAM with a needle length of 2 mm, a 5 mm sucker hole diameter, and 45° needle 
angle was chosen due to those parameters having been tested previously. Two different 
vacuum volumes were used, 0.25 cm
3
 and 0.35 cm
3
. These volumes were chosen from 
the results of the vacuum volume test which will be discussed later. Furthermore, mucus 
in the intestine may be sucked into the vacuum chamber during the attachment process 
and inhibit the working vacuum. Thus, the functionality of the TAM and the ICR with 
(and without) mucus was also investigated by scraping mucus from inside the intestine 
downstream from the anticipated attachment location and inserting a liberal amount of it 
into the ICR through the suction hole. The four different combinations of ICRs (0.25 cm
3 
/ 0.35 cm
3
 vacuum volumes, with or without mucus in the ICR) were each tested three 
times. Each configuration was tested with the full ICR assembly including the electronics, 
valve, and timing sequence. This is the first time the completed assembly has been tested. 
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Each ICR configuration was inserted such that its long axis was parallel to the 
longitudinal axis of the small bowel. It was inserted midway into an approximately 15-20 
cm long section of porcine small intestine and tested at room temperature. The only 
external force applied to the capsule during this test was to push it past the incision point 
and into place. Once in place, no external force was applied to the tissue or the capsule to 
aid in adhesion (or for any other purpose). The intestine was stored in saline (NERL 
blood bank saline, Thermo Inc.) and used within 30 hours of excision to avoid 
deterioration of tissue properties 
165
. After insertion, the ICR was activated by sweeping a 
magnet across an integrated reed switch and after a five-second delay it captured the 
tissue. One end of the tissue was then attached to a tensile testing machine (ADMET 
eXpert 5601, ADMET Inc.) and the other end was free. Two strings were attached to both 
ends of the ICR and the TAM as shown in Fig. 4-9.  
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Fig.4-9 In vitro experiment test setup. Integrated ICRs were inserted into a fixed fresh 
intestine tissue, then the ICR was activated and pulled by a tensile test machine, and the 
force which separated the ICR from the TAM was recorded. Similar to the separation 
test, the string on the TAM was pulled and the force which detached the TAM from the 
tissue was recorded. 
The tensile testing machine then pulled on the string attached to the ICR after the 
separation of the TAM and ICR was observed. The maximum forces were recorded as 
separation forces and were compared to the maximum expected peristaltic traction force 
of a human intestine 
166
. In each experiment, the force of the ICR weight pulling on the 
load cell was subtracted from the reading. This force indicated the TAM ejection 
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efficiency which is critical to ensure the ICR is not retained in the small intestine. Similar 
to the separation force test, the maximum pull force required to separate the TAM from 
the tissue was also recorded in an independent test run. This attachment force indicated 
the attachment strength of the TAM deployed by the ICR. The attachment forces were 
also recorded with intestinal mucus being placed in the ICR suction hole prior to the test. 
The reliability of the ICR was also investigated independently. Sixteen ICRs (8 
ICRs for each vacuum volume) were placed in the intestinal tissue one by one and were 
activated to perform the entire aspiration-ejection-separation sequence, and the aspiration 
and separation rates were recorded. The reliability of the ICR was analyzed based on the 
results. 
The vacuum volume of the ICR for the following in vivo animal testing was 
determined from the results. 
4.2.3.3 In vivo Animal Experiment 
To investigate the TAM deployment function and attachment duration in vivo, a 
70 kg crossbred, neutered, domestic pig was selected for this study. The animal received 
humane care according to the Guide for the Care and Use of Laboratory Animals 
prepared by the U.S. Department of Health and Human Services and published by the 
National Institutes of Health (NIH). The study was approved by the University of 
Nebraska-Lincoln’s (UNL’s) Institutional Animal Care and Use Committee (IACUC, 
Protocol No. 887). An ICR with a vacuum volume of 0.35 cm
3
 was used to deploy the 
TAM. The self-localization features of the capsule are beyond the scope of this project, 
so to ensure the TAM deployed in the proper location, the ICR was implanted via 
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enterotomy instead of via swallowing. According to a previous study, the difference in 
intestinal contact pressure on a solid bolus between a closed and an open abdomen is 0.28 
kPa 
69
. Thus, the ICR ejection performance under surgical implantation conditions (with 
an open abdomen) is likely similar to the performance of a capsule that is swallowed and 
activates in a closed abdominal pressure environment. Prior to surgery, the pig fasted for 
24 hours. An abdominal laparotomy was performed to expose a section of the jejunum, 
and the ICR was inserted along its long axis direction through an approximately 15 mm 
jejunal incision and then pushed 10 cm aboral to the incision. The ICR was then activated 
remotely via a magnetic field. No external force is applied between the ICR and the tissue 
to improve attachment during the capture process. After observing that the tissue was 
partially aspirated by the ICR, the enterotomy was sutured closed and a radiopaque 
marker was sutured on the intestinal mesentery close to the ICR position. This marker 
enabled tracking the migration of the ICR and TAM from the implant site. Radiographs 
were taken prior to recovery from anesthesia to record the initial locations of the TAM. 
Ventral dorsal (VD) and lateral abdominal X-ray images were taken to establish the 
initial position. The pig was recovered and returned to the stall, following which 
radiographic images were acquired four hours after recovery, then every twelve hours 
until the TAM appeared to detach. The pig had free access to food and water for the 
duration of the experiment and veterinary staff monitored the behavior and body 
temperature of the pig to detect signs of discomfort or sepsis. After the detachment of the 
TAM was confirmed by X-ray, the time was recorded as the attachment duration and 
end-point of the study. The pig was euthanized right after and the tissue from the TAM 
attachment position was collected for a histological survey. In addition to this test, the 
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same in vivo experiment was performed a second and third time using four and two ICRs 
in the second and third experiments, respectively. The purpose of repeating the in vivo 
studies was to provide a repeatable measure of attachment success and duration. 
4.2.3.4 Histopathology trauma identification 
To identify the possible damage caused by the TAM attachment, tissue from the 
attachment location was collected from the pigs immediately after humane euthanasia 
and fixed in 10% neutral buffered formalin. Two adjacent pieces of tissue 100 mm orally 
and aborally of the ICR were analyzed as a control. Cross sections of the intestines at the 
sites marked with radiopaque markers were collected and processed (Sakura VIP 5 Tissue 
Processor) for histological evaluation the next day after fixation. Paraffinized sections 
were cut at 4 μm thickness and were stained with hematoxylin and eosin (Ventana 
Symphony Stainer). The samples were evaluated by a board certified veterinary anatomic 
pathologist to describe the presence or absence of inflammatory changes in the sections. 
4.3 Results 
Following are the results of validation of the ICR to meet the functional 
requirements.  
4.3.1 Vacuum Volume Test 
Fig. 4-10 shows the average residual vacuum pressure for each vacuum volume 
tested. Ideally, the residual vacuum pressure should be as small as possible to allow the 
spring to successfully eject the TAM. As shown in the figure, the residual vacuum 
pressure decreases as the vacuum volume decreases (as expected), until the vacuum 
volume is decreased below approximately 0.23 cm
3
. After this point, the TAM no longer 
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successfully captured tissue. The residual vacuum pressure rises after the TAM no longer 
captures tissue due to the vacuum no longer aspirating the tissue because it cannot 
overcome the elasticity and viscous friction between the tissue and the ICR. This causes 
the final volume to be larger, increasing the final vacuum pressure magnitude. 
 
Fig.4-10 Residual gauge vacuum pressure after capturing tissue. All measurements are 
shown; the line is the mean. 
Using this test, the two volumes to be used in the in vitro experiment were chosen 
as 0.25 cm
3
 and 0.35 cm
3
. The 0.25 cm
3
 volume was chosen since it was determined that 
a volume below 0.23 cm
3
 does not capture tissue, this gives a margin of error for the 
manufacturing of the ICR’s internal volume. The 0.35 cm3 volume was chosen to 
discover if an increase in vacuum volume provides any significant improvement in 
performance. 
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4.3.2 In vitro experiment 
As can be seen in Fig. 4-11, an ICR with 0.35 cm
3
 vacuum volume performed 
slightly better than the 0.25 cm
3
 vacuum volume configuration. The attachment force of 
the TAM applied by the 0.35 cm
3
 ICR increased 17% and 43% in no-mucus and mucus 
cases compare to the 0.25 cm
3
 ICR. Meanwhile the separation force needed decreased 27% 
which means the separation process would be easier. 
 
Fig.4-11 Attachment/separation forces for ICR samples with different vacuum volumes.  
However, using a one way ANOVA table for the attachment/separation force, it 
was determined that none of the variables (vacuum volume and mucus) had a statistically 
significant effect on the ICR performance. This means that the ICR is not highly sensitive 
to changing parameters and allows for some variability in the design at current size range.  
The presence of mucus in the suction chamber enhanced the attachment 
performance of the TAM in both vacuum volume configurations. One possible 
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explanation might be that mucus works as lubrication and allows the needles to penetrate 
the tissue more easily and deeply, hence achieving firmer attachment.  
The mean separation forces of the both ICRs (0.96 N-1.31 N) are still higher than 
the average human peristaltic traction force (0.6N) 
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, but 50% (3 out of 6) of the ICRs 
separated with a force less than 0.6N. 
Due to the better performance of the larger vacuum volume, the 0.35 cm
3
 ICR 
will be used in the in vivo test. Considering that only 0.35 cm
3
 out of the 2.5 cm
3
 volume 
is used as the vacuum chamber in the ICR body, there is still a large amount of available 
space in the ICR body that can be eliminated to shrink the overall size. This size 
optimization process will be conducted in the future. 
For the reliability test, of the 16 total trials run with the ICRs, 2 were excluded 
due to electrical circuit failure. Out of the 14 remaining ICRs, all aspirated tissue as 
expected for an aspiration success rate of 100%. The success rate of separating the TAM 
from the ICR after aspiration was 78.57% (11 out of 14 capsules). 
4.3.3 In vivo animal experiment 
Body temperature measurements by the veterinary staff were in the normal range 
of a healthy pig during the test. As can been seen from Fig. 4-12, the TAM could 
successfully aspirate nearby tissue and separate from the ICR.  
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Fig.4-12 Capsule inserted into the intestine showing successful aspiration and separation. 
A radiopaque marker is sutured at the same location.  
The results from the first animal study are shown by inverted contrast lateral 
abdominal radiographs of the pig in Fig. 4-13. In the subfigures, the small black rod is the 
radiopaque marker on the intestinal mesentery. The TAM is indicated by a circular 
pattern of needles, which is the only radiopaque portion of the TAM (Fig. 10a). Another 
capsule unrelated to this study is also visible in these images, but it was located in a 
different position of the intestine so it would not affect the result of this study. From the 
X-ray images, it was clear that the TAM separated from the ICR successfully after 16 
hours (Fig. 4-13c). The ICR kept moving downwards along the intestine while the TAM 
stayed fixed relative to the stationary mesenteric marker. The dashed circles in Fig. 4-
13d-f show the location of the TAM with respect to the marker with a zoomed-in view in 
Fig. 4-13c. Based on the results from the radiographs, the attachment lasted at least 40 
hours and detachment was observed by 52 hours (Fig. 4-13f).  
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Fig.4-13 TAM deployment process and its duration in a live porcine model. (a) X-ray 
image taken before the recovery of pig. (b) X-ray image taken 4 hours after recovery. (c) 
X-ray image taken 16 hours after recovery. (d) X-ray image taken 28 hours after 
recovery. (e) X-ray image taken 40 hours after recovery. (f) X-ray image taken 52 hours 
after recovery; the TAM was detached at this point.  
For the second and third in vivo experiments, no attachment duration 
improvement of the TAM occurred, and only 3 out of 7 ICRs separated from the TAM 
successfully according to the X-ray images. Compared to the separation rate acquired 
during the in vitro study, the reliability of the ICR in vivo decreased from 78.57% to 
42.85%. A possible reason for the decrease in success rate is the different biomechanical 
properties of the intestinal tissue in vitro versus in vivo or imperfections of the ejection 
mechanism. A full investigation of the tissue and ICR behavior in vivo will be conducted 
in future work.  
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4.3.4 Histology 
Tissue from the attachment and control locations of the first animal test (only one 
ICR tested in this procedure) were collected and processed for the histology study. The 
results were shown below (Fig.4-14).  
 
Fig.4-14 Histology microscope images. (a) Microscope image of the intestinal tissue at 
the attached position. (b) Control tissue collected 10 cm orally from the attached position. 
(c) Control tissue collected 10 cm aborally from the attached position. 
At the attachment area, there is a 0.85-1.35 mm thick crust of neutrophils, fibrin, 
eosinophils, and cell debris with small amounts of hemorrhage along the surface of the 
mucosa. Some moderate inflammatory changes at the site of attachment and changes 
associated with the incision are observed. These are normal phenomena after surgery and 
suturing. No serious trauma or inflammation was observed from this site. Mild 
proliferation of slightly plump fibroblasts and collagen focally along the serosa due to the 
surgical stimulation were also found in both controls, which, with the occurrence of the 
crust, may provide an explanation for the intestine thickening phenomenon and natural 
detachment we observed from our previous TAM test 
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. This natural detachment caused 
either by sloughing of the mucosa, tissue thickening, or some other unknown 
phenomenon is the current mechanism we relied on to detach the TAM after a long-
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period dwell (one week). These phenomena will need to be addressed if the very long-
term attachment is pursued (weeks to months). Also, a more device-controlled 
detachment mechanism is planned if the tissue thickening is proven problematic or 
dangerous to the host. In the third in vivo experiment, a single inflammatory polyp was 
found on one of the TAM attachment sites. In general, the inflammatory polyp was found 
most often in animals with an inflammatory bowel disease and it is a typical reaction to 
chronic inflammation in the GI. This phenomenon may have been caused by unsterilized 
needles, a non-biocompatible material in the attachment mechanism, or that the 
attachment process itself causes undesirable stimulations to the intestinal tissue (infection, 
bleeding and tearing). A comprehensive animal experiment using more than 20 ICR 
samples will be performed in our following study and the pathogenesis of the polyp and 
the damage will be investigated both biologically and statistically with image analysis 
processing. Furthermore, the device used in future work will use biocompatible and 
sterile components. 
4.4 Conclusion 
The attachment forces based on in vitro testing are nearly equivalent to the results 
achieved by manually deploying the TAM with infinite vacuum in our previous work. 
Although 50% of the ICRs required more force to separate the ICR from the TAM than is 
typically generated by the small intestine, the results were different for in vivo testing. As 
can be seen in the X-ray images, the TAM separated successfully, possibly because in 
vivo the ICR is subjected to cyclic peristaltic waves over a long period of time which will 
be advantageous to separating the ICR from the TAM. Furthermore, it is likely that the 
vacuum pressure gradually dissipates over longer time scales than were used in the in 
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vitro tests. There is also the possibility that the fluidic drag of chyme on the ICR helped it 
to separate from the TAM. These theories have not yet been tested and are the subject of 
future work. The in vivo test verified the proper functioning of the ICR system, and 
histology indicated this attachment method does not cause unacceptable damage to the 
host. Compared to our previous single in vivo TAM test, the attachment duration of the 
integrated TAM with ICR decreased from six days to less than 52 hours. This may 
indicate that the process of separation by pulling the ICR from the TAM under periodic 
intestinal peristalsis may cause a weakening of the TAM attachment strength and 
duration. Thus, a separation mechanism that functions with less force will be investigated 
in future work. The final goal is to develop a system with the most flexibility that can 
achieve very long-term attachment (weeks to months), but that can be modulated for 
shorter durations based on the application. Future work will also include additional 
animal tests and corresponding histology in order to acquire statistically significant 
results of the whole ICR implantation process. As mentioned, a very important 
component of the ICR technology is self-localization, which will enable the TAM to 
activate at the correct point in the small intestine. Ongoing work is pursuing this goal. 
The ICR will also need to be miniaturized to within acceptable swallowable size limits of 
11 mm by 30 mm. 
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CHAPTER 5. FINITE ELEMENT METHOD (FEM) SIMULATION OF THE 
INTERACTION OF INTESTINAL TISSUE AND TAM 
5.1 Background 
In chapter 3 we presented the details of a type of tissue attachment mechanism 
inspired by tapeworm scolex which could attach a biosensor to the target intestinal tissue 
and maintain its position up to six days. The TAM system includes a sucker with vacuum 
chamber and several needles integrated onto the sucker. When the TAM arrives at the 
ideal position, a slight vacuum is generated at the sucker surface. The suction function of 
the vacuum aspirates a small amount of tissue into the sucker to be grasped by the 
needles, and then it facilitates long-term attachment by fixing the tissue on those needles.  
In this method, the efficiency and rate of success depends on how deep the tissue could 
be aspirated into the sucker: the more tissue in the sucker, the higher chance the needle 
could attach to the tissue firmly. But higher vacuum pressure also may cause more 
serious damage to the tissue. To better understand this procedure and find the equilibrium 
of efficiency and safety, a numerical model is needed to study and predict the tissue 
behavior under different loading. Besides the attachment process, any controlled 
locomotion or drug releasing function of a multifunctional CR would technically require 
manipulating nearby tissue in certain manner. If a model could be built to analyze the 
tissue behavior under the manipulating process, it will shorten the design time and help 
the following product iteration. 
Typical soft tissue like the small intestine is nonlinear, anisotropic, viscoelastic 
material. To model the behavior of this kind of material through any analytical model is 
almost impossible and inaccurate. On the other hand, FEM could provide a better 
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approximation of bio-tissue behavior due to its excellent non-linear ODE/PDE solving 
ability that has been used to simulate tissue behavior for a long time. The goal of this 
work is to address this problem by simulating the deformation process of tissue under 
different vacuum pressure using FEM commercial software. The deformation trend, 
stress and strain distribution would help us optimize the TAM structure and minimize the 
possible damage to the tissue.  
The most challenging part in this numerical modeling is to simulate the needle-
tissue interaction. Since the TAM adheres to tissue rely on pure mechanical needle 
fixation. The attachment quality is mainly determined by how the needle interacts with 
the tissue. Currently, no experimental approaches could allow the authors to observe the 
on-site behavior of tissue and needle in the capsule. The design and optimization to 
enhance the attachment performance were based on test and intuitive understanding. 
Under such circumstances, the model is expected to provide significant information 
including the depth of needle penetration under certain vacuum pressure and the drag 
force the mechanism could bear under such fixation condition. To be able to offer such a 
rich depth of diagnostic and developmental guidance, it is necessary for the model to 
embed an appropriate failure mechanism for needle insertion. In FEM commercial 
software, the cohesive element was first introduced as a method to modeling the spot-
welded joints or super glue layer. Now, this method has been wildly applied in crack 
propagation analysis as the elements only need to be deployed along the insertion path 
which saves a lot of computing resources 
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. In addition, the cohesive element method 
utilizes simple energy approach and ease of incorporation into existing models with 
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normal, shear and combined load condition makes them the first choice to the work 
undertaken here.  
As a methodology development work, we believe the method shown in this work 
may also be applied in other tissue manipulation procedure analysis and become an ideal 
complement to the experimental validation. 
5.2 Methods 
5.2.1 Materials validation 
      The first step to simulate the tissue behavior is always to define the material 
properties properly. Hyperelasticity (nonlinear stress increase with strain) of intestine 
tissue was shown in both uniaxial and biaxial tensile tests, and clear viscoelasticity was 
exhibited in relaxation tests.  
 
Fig.5-1 stretch-stress results for proximal, middle, and distal tissue samples. Curves that 
are indicated with an L are stretched along the longitudinal direction, and C indicates the 
circumferential direction 
101
. 
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Those properties are attributed to the micro level tissue texture and multilayer 
structures. Currently no physically laws under continuum assumption could fully descript 
such complex behavior, physically-motivated model (Arruda-Boyce model or Van der 
Waals model) are normally applied when there are limited test data. For the intestine 
tissue which is fully tested here, phenomenological models such as polynomial, Ogden, 
Marlow model are more popular and more accurate in modeling the hyperplastic behavior.  
Phenomenological model, as the name implies, is not directly derived from physical 
theory, instead a mathematical model which determine its parameters by fitting the 
experiment data. 
For the hyperelasticity, uniaxial and biaxial tensile test data were collected from 
Terry’ s work 101. Marlow, second order polynomial and Ogden model were applied in 
Abaqus to fit those data. Those models are expressed in terms of a strain energy potential 
as shown in Eq. (5-1) - (5-3): 
Polynomial model:  𝑈 = ∑ 𝐶𝑖𝑗
𝑁
𝑖+𝑗=1 (𝐼1̅ − 3)
𝑖(𝐼2̅ − 3)
𝑗 + ∑
1
𝐷𝑖
𝑁
𝑖=1 (𝐽𝑒𝑙 − 1)
2𝑖   (5-1)     
where U is the strain energy potential; Jel is the elastic volume ratio; I1 and I2 are 
the first and second invariants of the deviatoric strain; and N, Cij, and Di are material 
constants.  Cij describes the shear behavior of the material, and Di introduces 
compressibility. 
Ogden model:   𝑈 = ∑
2𝜇𝑖
𝑎𝑖
2
𝑁
𝑖=1 (𝜆1
𝑎𝑖
+ 𝜆2
𝑎𝑖
+ 𝜆3
𝑎𝑖
− 3) + ∑
1
𝐷𝑖
𝑁
𝑖=1 (𝐽e𝑙 − 1)
2𝑖       (5-2)   
where𝜆𝑖 = 𝐽
−
1
3𝜆𝑖 , λi are the principal stretches and J is the volume ratio. The 
constants µi and ai describe the shear behavior of the material, and Di, the compressibility. 
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Marlow model:  𝑈 = 𝑈𝑑𝑒𝑣(𝐼1̅) + 𝑈𝑣𝑜𝑙(𝐽𝑒𝑙)                                                        (5-3) 
where U is the strain energy per unit of reference volume, with Udev as its 
deviatoric part and Uvol as its volumetric part. The deviatoric part of the potential is 
defined by providing uniaxial, equibiaxial, or planar test data; while the volumetric part is 
defined by providing volumetric test data, defining the Poisson's ratio, or specifying the 
lateral strains on the uniaxial, equibiaxial, or planar test data. 
For the viscoelasticity, a five-element viscoelasticity model shown below (Fig. 5-
2) was applied to descript the viscoelastic properties and the tissue stress-strain 
relationship and interpreted into a time dependent Prony series in Abaqus 
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. The tissue 
was considered as isotropic materials in this work to simplify the calculation.  
 
Fig.5-2 Five-element viscoelasticity model of porcine intestine tissue 
102
.  
This five-element model was introduced by Kim et al. Its stress relaxation can be 
expressed as the following Eq. (5-4):  
                        𝜎(𝑡) = 𝜀0[𝐸1 𝑒𝑥𝑝 (−𝑡 ∙
𝐸1
𝜂1
) + 𝐸2 exp (−𝑡 ∙
𝐸2
𝜂2
) + 𝐸3]                       (5-4) 
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Where, E1, E2 and E3 indicate the elastic moduli of springs and η1, η2 are the 
viscosities of dashpots shown in the model schematic. Also, ε0 is the constant strain 
applied to the intestine for the relaxation test. 
Table 1 presents the value of each element in the stress relaxation model obtained 
from non-linear curve fitting with respect to the experimental result of strain 0.16 which 
is the strain value generated in the intestine by inserting a capsule with 10 mm diameter. 
The 10 mm diameter capsule is closed to our capsule size (13mm) which will be used to 
define the viscoelasticity of the intestine. 
Table 1 The value of each element of the viscoelasticity model. 
Relaxation model Value 
E1(kPa) 7.0 
E2(kPa) 6.3 
E3(kPa) 9.2 
η1(kPa s) 125.9 
η2(kPa s) 10.3 
This relaxation was then interpreted into a time dependent Prony series as shown 
in Eq. (5-5): 
                             𝐺(𝜏) = 𝐺0[1 − ∑ 𝑔𝑖
𝑝𝑁
𝑖=1 (1 − 𝑒
−
𝜏
𝜏𝑖
𝐺
)]                                             (5-5)                
Where G(τ) is the relaxation modulus and gi and τi are the material coefficient. 
Here G0 is determined from the hyperelasticity definition. The coefficients were 
calculated from the data in table 1 as g1=0.31, g2 =0.28, τ1 =18. τ2 =1.6. 
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5.2.2 2D simulations 
      Simulations with 2D models were more computationally efficient. In this 
work, a 2D tissue deformation model was set up as shown in Fig. 5-3. A flat 2D 
rectangular part was set as intestinal tissue and a hemi-sphere structure under it replicate 
the sucker. The density of intestine tissue was measured as 0.83 g/cm
3
 and accepted here. 
 
Fig.5-3 2D simulation setup. 
      The sucker was treated as rigid body in the simulation because of its relatively 
high hardness and small deformation during the test. Needles weren’t considered in both 
2D and 3D simulations in this step.  
      Before the simulation starts, a 0.04 MPa pressure was applied to the bottom of 
the tissue. A 0.5s dynamic step was introduced and an explicit solver was used to 
calculate the deformation. The friction coefficient was first as zero then increased step by 
step to investigate its effect to the simulation stability. The “hard” contact property was 
defined between the intestinal tissue surface and the corresponding TAM surface. After 
the simulation was done, the load was decreased to 0.02 MPa respectively and the test 
was run again. 
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5.2.3 3D simulations 
      Simulations with 3D models were also set up as shown in Fig. 5-4 to obtain 
more accurate results. Only the top half of the sucker mechanism and tissue was modeled 
to reduce the calculation time and symmetric boundary conditions was applied to the 
truncation surface. Soft tissue usually contains a large volume of water and water is 
generally incompressible material. So the tissue was treated as nearly incompressible 
material (Poisson’s ratio=0.48) in this work. The load pressures were same as the above 
step. A Tetrahedral element C3D10M was used to mesh the tissue and totally 151245 
elements were created to capture the geometry of the tissue. Maximum stress and strain 
were analyzed after the simulation. 
 
Fig.5-4 3D simulation setup. 
5.2.4 Needle-tissue interaction  
In cohesive element method, the cohesive response between the two parallel faces 
of a four nodes element is based on a bilinear traction-separation relationship. This 
relationship determines how the cohesive element behaves until it is failed and removed 
from the simulation (Fig. 5-5).  
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Fig.5-5 Traction-separation relationship for cohesive elements, which the triangular area 
represents the fracture toughness. 
As the surfaces separate (crack caused by needle insertion), traction first increases 
until a maximum tc is reached, and then subsequently reduces to zero which results in 
complete separation. The separation causing damage initiation and resulting in total 
element failure is δc and δ0 correspondingly. The area under this curve is equal to the 
energy needed for separation i.e. the cohesive fracture energy Gc (or fracture toughness).  
In Abaqus, the cohesive element has zero thickness therefore it does not represent 
any physical material but describes the cohesive forces which occur when material 
elements are being pulled apart. To eliminate numerical errors caused by zero thickness, 
a constitutive thickness Tc is implemented. For 2D cases, the normal and shear strain 
could be evaluated in Eq. 5-6. 
𝜀𝑛,𝑠 =
𝛿𝑛,𝑠
𝑇𝑐
                                                          (5-6) 
The 𝛿𝑛,𝑠  represent the normal and shear separation of two cohesive element 
surface. 
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The strain is related with the traction by stiffness term 𝐾𝑛𝑛,𝑠𝑠 as Eq. 5-7 
{𝑡𝑛
𝑡𝑠
} = [
𝐾𝑛𝑛 𝐾𝑛𝑠
𝐾𝑠𝑛 𝐾𝑠𝑠
] {𝜀𝑛
𝜀𝑠
}                                          (5-7) 
For simplification, the off-diagonal terms 𝐾𝑛𝑠,𝑠𝑛 were removed from the 
calculation and the tissue crack propagation properties were set to be isotropic (i.e.𝐾𝑛𝑛 =
 𝐾𝑛𝑠 ). The constitutive thickness is chosen to be 1 
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. Under such circumstances, the 
stiffness term is numerically equal to the slope of left side shown in Fig. 5-5. Namely, if 
the fracture energy Gc (a natural property of the material) and the failure separation δ0 
(determined by the diameter of needle) are both known, the entire cohesive element 
behavior could be properly descripted according to the equation of a triangle (Eq. 5-8).  
{
𝑇𝑐 =  
2𝐺𝑐
𝛿0
𝐾𝑛𝑛 =  
2𝐺𝑐
𝛿𝑐𝛿0
                                                          (5-8) 
A 2D model which represents the insertion of a 1 mm diameter needle into a 100 
mm × 80 mm soft tissue at 100 mm/sec speed was built to validate the method (Fig.5-6). 
The Gc was set to be 80 J/m
2 
(close to liver tissue), the separation parameter δc and δ0 
were chosen as 0.8 mm and 0.9 mm (so complete failure of the cohesive element occurs 
due to the needle’s 1mm diameter). Therefore the maximum traction tc and the stiffness 
term K are calculated as 177.7 kPa and 2.22 × 10
8
 N/m
3
. The friction was defined using 
Coulomb friction law as 0.2. 
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Fig.5-6 The cohesive element method validation setup. 
Then the validated cohesive method was integrated into a 2D simulation model as 
shown in Fig.5-7. Compare to the 2D aspiration simulation, two needles were built on the 
TAM also two cohesive layers were embedded in the tissue. 
 
Fig.5-7 The 2D simulation of needle penetration with cohesive element method setup. 
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5.3 Results 
5.3.1 Materials Validation 
      Materials validation results were shown in Fig.5-6.  The loading for 
viscoelasticity validation is a 10 mm elongation. 
 
Fig.5-8 Material model test data fitting. A) Creep compliances. B) Shear Relaxation 
modules. C) Uniaxial tensile data fitting. D) Biaxial tensile data fitting. 
  The creep and relaxation fitting curve showed reasonable viscoelastic 
performance as expected. For the hyperelastic behavior (Fig. 5-8 C, D), Marlow model 
didn’t fit the biaxial tensile test data well. The 2nd order Polynomial model showed its 
advantage in biaxial test fitting but also had departure trend in uniaxial tensile test fitting 
97 
 
when the tissue went into the highly non-linear part (Strain >0.35). Therefore the Ogden 
model was chosen to descript the tissue tensile behavior due to its nice non-linear fitting 
performance. 
5.3.2 Convergence checking 
The element number applied in the 3D simulation was doubled to check the 
convergence of the results. With doubled elements, the results only show 2% variation 
but the total execution time prolonged from 22 hours to 4 days. Therefore, current mesh 
density is considered as the best choice to reach the equilibrium between the 
computational accuracy and computational resources. 
5.3.3 2D simulations 
As can be seen in Fig. 5-9, the maximum von Mises stress of tissue under 0.04 
MPa vacuum pressure was 0.23 MPa, increased 53% as the stress under 0.02 MPa 
vacuum (0.15 MPa). On the other hand, the strain only increased 16% from 1.25 to 1.05 
when the vacuum load got doubled.    
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Fig.5-9 2D deformation of tissue under 0.04 MPa and 0.02 MPa vacuum pressure. A) 
Stress and strain plots at 0.04 MPa. B)  Stress and strain plots at 0.02 MPa. 
It was clear from the tensile test data that the tissue was in highly non-linear 
stress-strain part when the strain beyond 0.35, it explains why the stress increases more 
rapidly than strain and the results are considered reasonable. Strain at the fixed boundary 
was unneglectable small (around 0.2) which indicated fixed boundary assumption is not 
accurate, unsimplified model contain the whole aspriation geometry might be more 
suitable for the case. The increasing firction had minor influence to the final results but 
when the coeffienct exceeded 0.4, the simulation became unstable, implicit solver will be 
investigate in future due to its unconditional stability. For the following simulations, only 
0.2 firction coefficient will be applied.     
5.3.4 3D simulations 
To demonstrate the influence of the TAM geometry on the tissue deformation and 
stress concentration, only the results of 0.04 MPa vacuum load were shown in Fig. 5-10. 
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Fig.5-10 3D deformation of tissue under 0.04 MPa vacuum pressure. A) Stress Plot. B)   
Strain Plot. 
Maximum principal strain was 1.07 marked as red region on Fig. 5-10B after 0.5s 
vacuum load. The tissue expanded three dimensionally under this dynamic step 
simulation and the deformation shape was closer to the reality.  Consider hyperelastic 
materials like rubber usually could sustain 400% strain without any defects, this strain 
was considered as safety.  
  More interesting phenomenal was noticed when the value and location of the 
maximum von Mises stress was analyzed. The maximum stress was 9 MPa, almost 40 
times larger than the 2D simulation, but as shown in Fig.5-11, the maximum stress didn’t 
appear on the bottom surface like 2D results, instead it occurred in the wrinkles of the 
tissue when the tissue was squeezed into the suction hole (Fig. 5-10). 
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Fig.5-11 Maximum von Mises stress in 3D simulation appears in the wrinkles of tissue. 
In the wrinkle area, tissue was forced to press against each other, because the 
intestinal tissue is nearly incompressible material and there is no extra space allow the 
tissue to deform and absorb the energy in the hole area, stress concentration occurred. In 
other words, stress concentration or even tissue damage may not be caused by the tension, 
but by the compression.  
A 9 MPa stress was deliberately applied on a fresh small intestine tissue for 10 
min to check the possible damage. Histology shows a moderate infiltrate of eosinophils 
and eosinophilic globular leukocytes throughout the lamina propria but no serious trauma. 
This information provides guidance to optimize the shape of the TAM sucker, an 
alternate sucker geometry in smooth conical shape will be designed in future, larger 
contact space on the top of the sucker would avoid creating the wrinkle appear and 
minimize the stress concentration.   
Besides the wrinkle area, maximum stress and strain at the spherical place is 0.19 
MPa and 1.07. It is close to the 2D results, 0.23MPa and 1.25, indicate that 2D model is 
101 
 
accurate enough to provide general information of the aspirated tissue. More intact 
information delivered by the 3D model may include unexpected discoveries. 
5.3.5 Needle-tissue interaction 
The cohesive element method behaved as expected on the validation model. The 
needle could penetrate the tissue successfully and generate stress waves along its 
insertion (Fig. 5-12).  
 
Fig.5-12 Stress plot of the needle penetrated into a block of soft tissue at different time 
points. 
The reaction force on the needle through insertion is extracted from the model and 
plotted as Fig. 5-13A. A standard force-displacement response was obtained using the 
needle from the TAM to penetrate a fresh porcine small intestine tissue (Fig. 5-13B). 
Despite the saw-toothed noise caused by vibration, the smoothed force plot shows that 
the cohesive elements are able to capture the realistic trend of a typical needle insertion 
process (Fig. 5-13B). In other words, the force is first increasing dramatically to initiate 
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the crack. External work is converted to the strain energy of the tissue, then the force 
decrease through the relaxation of the tissue and reaches steady-state through crack 
propagation. 
 
Fig.5-13 The force-displacement response for (A) cohesive model, (B) real needle 
insertion force response. 
Problems occurred when the cohesive element method was integrated into the 2D 
aspiration model. As the requirement for this method, the location of the crack must be 
known before modeling. But in our case, the location of the crack is impossible to be 
predetermined as can been seen in Fig. 5-14. The tissue is constantly deforming under 
such vacuum loading. At time point 0.15 s the needle has already contact with the tissue 
and is possible to penetrate the tissue at current condition. The crack path is shown as 
white dashed line in the upper image. At time point 0.25 s, the tissue is aspirated into the 
TAM deeper, if the penetration starts at this time point, the orientation and location of the 
crack path will be different from the previous condition. The penetration occurs at 
random depth level were observed in in vitro experiment. The reason was believed to be 
the different thickness and surface topography of tissue. 
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Fig.5- 14 Possible crack path at different aspiration time points. 
For such a case where it is impossible to predetermine the crack path, a popular 
approach is to distribute cohesive elements between continuum elements over an area 
where the crack can be expected to propagate. This method is called cohesive zone 
method and is expected to cost a huge amount of the computational resources. 
5.5 Conclusion 
In this chapter, FEM simulation using Abaqus was performed to analysis the 
deformation of intestinal tissue under certain vacuum load. Hyperelasticity and 
viscoelasticity properties were established using Ogden model. 2D and 3D simulation 
validate the materials definition and provide a theoretical basis to optimize the tissue 
attachment mechanism. Due to the difficulties of the integration of needle insertion 
behavior, needle fixation process is missing in this model and will be studied in the future.  
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CHAPTER 6. SUMMARY AND DISCUSSION 
6.1 Summary of current results 
Since the introduction of CE, wireless CR has been considered as a promising 
non-invasive platform to enter the GI tract and help the diagnosis and treatment of 
digestive disease. Besides camera imaging, the market is looking for an advanced CR 
which could actively locomote, attach and release the drug in the GI tract following 
controlled routine. The work we presented in previous chapters includes the detailed 
design and validation process of a long-term attachment CR. The CR is focusing on the 
attachment function and has the potential to be applied for long-term drug delivery. It has 
two functional subsystems: TAM and ICR which have been discussed in chapters 3 and 4. 
The TAM is a bioinspired attachment mechanism that realizes tissue adhesion by needle 
fixation. Thorough in vitro / in vivo experiments have proven that the TAM could attach 
to the intestinal wall for up to 6 days and cause minimal damage. Considering the face 
that no commercial CE has been able to maintain its position more than 24 hours, the 
TAM shows significant improvement in this field. In the future, other functional 
subsystems, including drug release mechanism or biosensors could be integrated on this 
TAM and expand the working duration from several hours to days. 
The ICR is a transport system which could deploy the TAM to the intestine and 
expel itself from the GI afterward. The degree of capsule automation is the key to 
achieving wireless controlled implantation. The current prototype utilizes a magnetic 
signal to activate the ICR which didn’t provide information of the ICR’s current location 
or orientation. Our ongoing project is to create on a localization subsystem as a 
combination of a gyroscope, a pressure sensor and the wireless communication circuit. 
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The localization system will allow the ICR to implant the TAM at any target position. 
The attachment duration through ICR deployment decreased from around 6 days to less 
than 52 hours. This indicates that the current deployment mechanism may not be able to 
reach the same efficiency as manual implantation. The energy loss in the spring ejection 
mechanism and the separation process is considered the main reason for this.  
With wireless CR, there is always a tradeoff between the power supply and the 
limited capsule size. After decades of research, a consensus has been reached that the 
biggest obstacle to developing a multifunctional CR is how to store sufficient power in 
swallowable dimensions. This relies on the progress of integrated circuits and battery 
technology. One of the reasons that CR is designed as a capsule is that its pill-like body 
has the most energy efficient shape to move through the GI tract with muscle peristalsis 
169
. To further improve the energy efficiency, a model which could simulate the 
interaction between the soft tissue and CR is definitely needed. In Chapter 6, we 
presented a preliminary FEM simulation study of the vacuum aspiration process. The 
study shows consistent results in most of the deformed area in 2D and 3D cases. The 3D 
model provided further stress concentration information on the tissue self-contact area. 
The hyperplastic behavior of tissue has been shown in both models and the vacuum 
efficiency can be estimated through the model.  
6.2 Future works 
The prototype we developed in this work focuses on the concept and function 
validation. In the future, the first step will be to improve the TAM attachment duration of 
ICR implantation to match the results of manual implantation. The main drawback of 
ICR implantation is that the force caused by TAM launching can weaken the attachment 
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strength, and we cannot eliminate this effect because the ICR implantation is 
automatically performed. The current sealing mechanism relies on tight cylinder contact 
coupling which exerts a large reaction force on the TAM during implantation. Ongoing 
work will be to optimize the ejection and separation mechanism to minimize the 
interaction forces generated during implantation. The possibility of replacing the spring 
ejection mechanism with more safety ejection method will also be studied. The capsule 
mechanical systems will also be updated continuously to decrease the overall dimensions. 
Even if the 6 days’ attachment is reached through ICR automatic implantation in 
future, there is still potential performance enhancement for this TAM. The natural 
detachment caused either by tissue thickening or sloughing of the mucosa prohibits 
further attaching of the capsule to reach its physical limitation. Iteration towards 
biocompatibility will be conducted when the design is freezed. The optimization will 
include using biocompatible stainless steel needles, biocompatible 3D printing materials 
which allow long-term mucosal contact or surface coating techniques. The improvement 
of biocompatibility may inhibit the sensitive tissue response and prolong the attachment 
duration. The possible complications through long-term needle penetration will be 
investigated pathologically and statistically through a thorough animal study. The general 
principle of firm mucosal attachment is to generate a certain type of contact and produce 
resistance against the peristalsis or fluid drag force. Attachment mechanisms other than 
the aspiration-fixation method to create mucosal contact can be the alternative approach 
to be investigated in the future. Barbed covered metallic stent has been proven efficient in 
preventing stent migration in esophagus 
170
. A similar mechanism, which could expand 
the barbed capsule surface to have contact with the intestinal tissue and maintain its 
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position, could be a solution to replace the current vacuum aspiration and spring ejection 
system. The pneumatically driven system is also a popular approach to actuate the 
colonoscopy robot to steer and move in the large intestine 
171
. The pneumatic expansion 
mechanisms which have been widely studied in this field can be applied to generate 
contact in large dimension area in the GI tract. The working site of the long-term 
attachment capsule robot can be extended to the whole GI tract with the aforementioned 
mechanisms. 
The long-term goal of this project is to generate in vivo attachment for months. To 
reach that, mucosal contact and fixation method in mesoscale may not be efficient 
enough due to the GI obstruction caused by its large size and the possible complications. 
One possible solution is to replicate the parasites scolex with hooks as a biomimetic 
adhesive patch. The parasitic adhesion has shown minimum damage to the host through 
long-term attachment. And the smaller size of micro-scale adhesive patches will also help 
to shrink the capsule size and benefit the long-term in vivo existence. Once a proper 
scolex shape is determined through our developed strength test method, microfabrication 
techniques like two-photon polymerization can be applied to generate any complex 3D 
shape pattern in micro-level and its strength can be enhanced through surface coating.  
The present study of the FEM simulation is limited to a pure vacuum aspiration 
process. In order to characterize the needle fixation procedure, the cohesive element 
method was investigated but was not integrated into the aspiration model successfully. 
The requirement of predetermination of the needle penetration location on a deforming 
body was the obstacle. Future work utilizing the cohesive zone method or other suitable 
fracture simulation approaches will be investigated and integrated into the model. It is 
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anticipated that such a model will enhance the understanding of tissue-capsule interaction 
and provide critical information to the further iteration of CR. 
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Appendix 
A-2-1 Tapeworm attachment strength test data. Note: values with w in the weight column 
are the weight of the whole tapeworm; the rest are weight of part of their body. 
Rat 
No. 
Tapeworm 
No. 
Start 
point(g) 
lowest 
point(g) 
End 
point(g) 
Weight 
(g) 
Calculated 
attachment 
force (g) 
Test date 
1 
1 99.374 99.340 99.372 0.16w 0.034 
8/11/2015 
2 98.884 98.863 98.863 0.294w 0.021 
2 
3 22.6404 22.6264 22.6398 0.0196 0.014 
8/31/2015 
4 19.0906 19.0716 19.0902 0.0212 0.019 
3 
5 17.3597 17.3513 17.3596 0.0305 0.008 
9/4/2015 
6 17.0060 16.9737 17.0059 0.0129 0.032 
7 16.8450 16.8354 16.8455 0.0100 0.010 
8 16.7022 16.6618 16.7015 0.0462 0.040 
9 16.5644 16.5375 16.5596 0.1109w 0.027 
10 16.3454 16.3375 16.3477 0.1321w 0.008 
4 
11 15.3156 15.2986 15.3161 0.0404 0.017 
9/9/2015 
12 15.0423 15.0242 15.0431 0.0214 0.018 
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A-4-1 Microcontroller code 
//Current capsule microcontroller code 
#include <xc.h> 
#include <stdint.h> 
//int reset, no code protect, no watchdog, int RC clock 
#pragma config MCLRE = OFF, CP = OFF, WDTE = 01, FOSC = INTOSC 
#define _XTAL_FREQ 16000000 
#define SWITCH PORTAbits.RA2 
void main() 
{ 
uint8_t cnt_1m; 
WDTCON = 0b010110; 
// 01011- 2s interval 
// -----0 disable WDT 
WPUA = 0b000000; 
ANSELA = 0b000000; 
INTCON = 0b10001000; 
TRISA = 0b100; //configures RA0 and RA1 as output 
//********************POWER ON BLINK********************** 
LATA = 0b000010; 
__delay_ms(75); 
LATA = 0b000000; 
__delay_ms(750); 
LATA = 0b000010; 
__delay_ms(75); 
LATA = 0b000000; 
WDTCON = 0b001101; 
// 00110- 64ms interval 
// -----1 enable WDT 
//wait for button press 
while(SWITCH==1){ 
SLEEP(); 
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} 
WDTCON = 0b001100; 
// 00110- 64ms interval 
// -----0 disable WDT 
//*****************DIAGNOSTIC MAGNET BLINK******************** 
LATA = 0b000010; 
__delay_ms(750); 
LATA = 0b000000; 
__delay_ms(100); 
LATA = 0b000010; 
__delay_ms(100); 
LATA = 0b000000; 
WDTCON = 0b001101; 
// 00110- 64ms interval 
// -----1 enable WDT 
//wait for button press 
while(SWITCH==1){ 
SLEEP(); 
} 
WDTCON = 0b001100; 
// 00110- 64ms interval 
// -----0 disable WDT 
//******************ACTIVATION BLINK****************** 
//Blink LED on RA1 three times 
/*LATA = 0b000010; 
__delay_ms(250); 
LATA = 0b000000; 
__delay_ms(250); 
LATA = 0b000010; 
__delay_ms(250); 
LATA = 0b000000; 
__delay_ms(250); 
LATA = 0b000010; 
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__delay_ms(250); 
LATA = 0b000000;*/ 
cnt_1m = 0; 
/*WDTCON = 0b010101; 
// 01010- 1s interval 
// -----1 enable WDT 
//**********************WAIT TIMER******************/ 
LATA = 0b000010; 
__delay_ms(1000); 
LATA = 0b000000; 
__delay_ms(1000); 
LATA = 0b000010; 
__delay_ms(1000); 
LATA = 0b000000; 
__delay_ms(1000); 
LATA = 0b000010; 
__delay_ms(1000); 
LATA = 0b000000; 
__delay_ms(1000); 
LATA = 0b000010; 
__delay_ms(1000); 
LATA = 0b000000; 
__delay_ms(1000); 
LATA = 0b000010; 
__delay_ms(1000); 
LATA = 0b000000; 
__delay_ms(1000); 
LATA = 0b000010; 
__delay_ms(1000); 
LATA = 0b000000; 
__delay_ms(1000); 
LATA = 0b000010; 
__delay_ms(1000); 
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LATA = 0b000000; 
/*while(cnt_1m < 13)//change this value to (number of seconds / 67) CHANGE 
THIS ERIC 
{ 
SLEEP(); 
++cnt_1m; 
} 
WDTCON = 0b010100;*/ 
// 01010- 1s interval 
// -----0 disable WDT 
//*****************TURN ON NICHROME BLINK************** 
LATA = 0b000010; 
__delay_ms(50); 
LATA = 0b000000; 
__delay_ms(50); 
LATA = 0b000010; 
__delay_ms(50); 
LATA = 0b000000; 
__delay_ms(50); 
LATA = 0b000010; 
__delay_ms(50); 
LATA = 0b000000; 
//turn on nichrome wire 
LATA = 0b000001; 
WDTCON = 0b100001; 
// 10000- 64s interval 
// -----1 enable WDT 
//**********************NICHROME ON TIMER********************* 
while(cnt_1m < 2)//change this value to the number of minutes of delay 
{ 
SLEEP(); 
++cnt_1m; 
} 
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WDTCON = 0b100000; 
// 10000- 64s interval 
// -----0 disable WDT 
//turn off nichrome wire 
LATA = 0b000000; 
for(;;)// loop FOREVER 
{ 
SLEEP(); 
} 
} 
 
